Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008

Error processing SSI file

References

  1. Garner JS, Favero MS. CDC Guideline for handwashing and hospital environmental control, 1985. Infect. Control 1986;7:231-43.
  2. Centers for Disease Control. Ambulatory and inpatient procedures in the United States, 1996. Atlanta, GA, 1998:1-39.
  3. Uttley AH, Simpson RA. Audit of bronchoscope disinfection: a survey of procedures in England and Wales and incidents of mycobacterial contamination. J. Hosp. Infect. 1994;26:301-8.
  4. Zaidi M, Angulo M, Sifuentes-Osornio J. Disinfection and sterilization practices in Mexico. J. Hosp. Infect. 1995;31:25-32.
  5. McCarthy GM, Koval JJ, John MA, MacDonald JK. Infection control practices across Canada: do dentists follow the recommendations? J. Can. Dent. Assoc. 1999;65:506-11.
  6. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann. Intern. Med. 1993;118:117-28.
  7. Weber DJ, Rutala WA. Lessons from outbreaks associated with bronchoscopy. Infect. Control Hosp. Epidemiol. 2001;22:403-8.
  8. Weber DJ, Rutala WA, DiMarino AJ, Jr. The prevention of infection following gastrointestinal endoscopy: the importance of prophylaxis and reprocessing. In: DiMarino AJ, Jr, Benjamin SB, eds. Gastrointestinal diseases: an endoscopic approach. Thorofare, NJ: Slack Inc., 2002:87-106.
  9. Meyers H, Brown-Elliott BA, Moore D, et al. An outbreak of Mycobacterium chelonae infection following liposuction. Clin. Infect. Dis. 2002;34:1500-7.
  10. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and-throat practice. N. Engl. J. Med. 1988;319:978-82.
  11. Centers for Disease Control and Prevention. Pseudomonas aeruginosa infections associated with transrectal ultrasound-guided prostate biopsies--Georgia, 2005. MMWR CDC Surveill. Summ. 2006;55:776-7.
  12. Mehta AC, Prakash UBS, Garland R, et al. Prevention of flexible bronchoscopy-associated infection. Chest 2006;128:1742-55.
  13. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:881-917.
  14. Spaulding EH. Chemical disinfection of medical and surgical materials. In: Lawrence C, Block SS, eds. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1968:517-31.
  15. Simmons BP. CDC guidelines for the prevention and control of nosocomial infections. Guideline for hospital environmental control. Am. J. Infect. Control 1983;11:97-120.
  16. Block SS. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001.
  17. Rutala WA, 1994, 1995, and 1996 APIC Guidelines Committee. APIC guideline for selection and use of disinfectants. Association for Professionals in Infection Control and Epidemiology, Inc. Am. J. Infect. Control 1996;24:313-42.
  18. Rutala WA. Disinfection, sterilization and waste disposal. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams and Wilkins, 1997:539-93.
  19. Rutala WA. APIC guideline for selection and use of disinfectants. Am. J. Infect. Control 1990;18:99-117.
  20. Association of peri-Operative Registered Nurses. Recommended practices for high-level disinfection. AORN J. 2005;81:402-12.
  21. Garner JS, Favero MS. CDC guidelines for the prevention and control of nosocomial infections. Guideline for handwashing and hospital environmental control, 1985. Supersedes guideline for hospital environmental control published in 1981. Am. J. Infect. Control 1986;14:110-29.
  22. Centers for Disease Control. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989;38:1-37.
  23. Centers for Disease Control. Guidelines for Environmental Infection Control in Health-Care Facilities, 2003. MMWR 2003;52 (No. RR-10):1-44.
  24. Bhattachatyya M, Kepnes LJ. The effectiveness of immersion disinfection for flexible fiberoptic laryngoscopes. Otolaryngol Head Neck 2004;130:681-5.
  25. Hamasuna R, Nose K, Sueyoshi T, Nagano M, Hasui Y, Osada Y. High-level disinfection of cystoscopic equipment with ortho-phthalaldehyde solution. J. Hosp. Infect. 2004;57:346-8.
  26. Foliente RL KB, Aprecio RM, Bains HJ, Kettering JD, Chen YK. Efficacy of high-level disinfectants for reprocessing gastrointestinal endoscopes in simulated-use testing. Gastrointest. Endosc. 2001;53:456-62.
  27. Kovacs BJ, Chen YK, Kettering JD, Aprecio RM, Roy I. High-level disinfection of gastrointestinal endoscopes: are current guidelines adequate? Am. J. Gastroenterol. 1999;94:1546-50.
  28. Rutala WA, Clontz EP, Weber DJ, Hoffmann KK. Disinfection practices for endoscopes and other semicritical items. Infect. Control Hosp. Epidemiol. 1991;12:282-8.
  29. Phillips J, Hulka B, Hulka J, Keith D, Keith L. Laparoscopic procedures: The American Association of Gynecologic Laparoscopists' Membership Survey for 1975. J. Reprod. Med. 1977;18:227-32.
  30. Muscarella LF. Current instrument reprocessing practices: Results of a national survey. Gastrointestinal Nursing 2001;24:253-60.
  31. Wright EP, Collins CH, Yates MD. Mycobacterium xenopi and Mycobacterium kansasii in a hospital water supply. J. Hosp. Infect. 1985;6:175-8.
  32. Wallace RJ, Jr., Brown BA, Driffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu. Rev. Microbiol. 1998;52:453-90.
  33. Mitchell DH, Hicks LJ, Chiew R, Montanaro JC, Chen SC. Pseudoepidemic of Legionella pneumophila serogroup 6 associated with contaminated bronchoscopes. J. Hosp. Infect. 1997;37:19-23.
  34. Meenhorst PL, Reingold AL, Groothuis DG, et al. Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J. Infect. Dis. 1985;152:356-64.
  35. Atlas RM. Legionella: from environmental habitats to disease pathology, detection and control. Environ. Microbiol. 1999;1:283-93.
  36. Rutala WA, Weber DJ. Water as a reservoir of nosocomial pathogens. Infect. Control Hosp. Epidemiol. 1997;18:609-16.
  37. Weber DJ, Rutala WA. Environmental issues and nosocomial infections. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams and Wilkins, 1997:491-514.
  38. Society of Gastroenterology Nurses and Associates. Standards for infection control and reprocessing of flexible gastrointestinal endoscopes. Gastroenterol. Nurs. 2000;23:172-9.
  39. Gerding DN, Peterson LR, Vennes JA. Cleaning and disinfection of fiberoptic endoscopes: evaluation of glutaraldehyde exposure time and forced-air drying. Gastroenterology 1982;83:613-8.
  40. Society of Gastroenterology Nurses and Associates. Guideline for the use of high-level disnfectants and sterilants in reprocessing of flexible gastrointestinal endoscopes.
  41. Turner AG, Higgins MM, Craddock JG. Disinfection of immersion tanks (Hubbard) in a hospital burn unit. Arch. Environ. Health 1974;28:101-4.
  42. Rutala DR, Rutala WA, Weber DJ, Thomann CA. Infection risks associated with spirometry. Infect. Control Hosp. Epidemiol. 1991;12:89-92.
  43. Kohn WG, Collins AS, Cleveland JL, Harte JA, Eklund KJ, Malvitz DM. Guidelines for infection control in dental health-care settings-2003. MMWR 2003;52 (no. RR-17):1-67.
  44. Sehulster L, Chinn RYW, Healthcare Infection Control Practices Advisory Committee. Guidelines for environmental infection control in health-care facilities. MMWR 2003;52:1-44.
  45. Rutala WA, White MS, Gergen MF, Weber DJ. Bacterial contamination of keyboards: Efficacy and functional impact of disinfectants. Infect Control Hosp Epidemiol 2006;27:372-7.
  46. Sattar SA, Lloyd-Evans N, Springthorpe VS, Nair RC. Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J. Hyg. (Lond). 1986;96:277-89.
  47. Weber DJ, Rutala WA. Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 1997;18:306-9.
  48. Ward RL, Bernstein DI, Knowlton DR, et al. Prevention of surface-to-human transmission of rotaviruses by treatment with disinfectant spray. J. Clin. Microbiol. 1991;29:1991-6.
  49. Tyler R, Ayliffe GA, Bradley C. Virucidal activity of disinfectants: studies with the poliovirus. J. Hosp. Infect. 1990;15:339-45.
  50. Gwaltney JM, Jr., Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am. J. Epidemiol. 1982;116:828-33.
  51. Sattar SA, Jacobsen H, Springthorpe VS, Cusack TM, Rubino JR. Chemical disinfection to interrupt transfer of rhinovirus type 14 from environmental surfaces to hands. Appl. Environ. Microbiol. 1993;59:1579-85.
  52. Sattar SA, Jacobsen H, Rahman H, Cusack TM, Rubino JR. Interruption of rotavirus spread through chemical disinfection. Infect. Control Hosp. Epidemiol. 1994;15:751-6.
  53. Rutala WA, Barbee SL, Aguiar NC, Sobsey MD, Weber DJ. Antimicrobial activity of home disinfectants and natural products against potential human pathogens. Infect. Control Hosp. Epidemiol. 2000;21:33-8.
  54. Silverman J, Vazquez JA, Sobel JD, Zervos MJ. Comparative in vitro activity of antiseptics and disinfectants versus clinical isolates of Candida species. Infect. Control Hosp. Epidemiol. 1999;20:676-84.
  55. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J. Clin. Microbiol. 1990;28:2234-9.
  56. Best M, Kennedy ME, Coates F. Efficacy of a variety of disinfectants against Listeria spp. Appl. Environ. Microbiol. 1990;56:377-80.
  57. Best M, Springthorpe VS, Sattar SA. Feasibility of a combined carrier test for disinfectants: studies with a mixture of five types of microorganisms. Am. J. Infect. Control 1994;22:152-62.
  58. Mbithi JN, Springthorpe VS, Sattar SA. Chemical disinfection of hepatitis A virus on environmental surfaces. Appl. Environ. Microbiol. 1990;56:3601-4.
  59. Springthorpe VS, Grenier JL, Lloyd-Evans N, Sattar SA. Chemical disinfection of human rotaviruses: efficacy of commercially-available products in suspension tests. J. Hyg. (Lond). 1986;97:139-61.
  60. Akamatsu T, Tabata K, Hironga M, Kawakami H, Uyeda M. Transmission of Helicobacter pylori infection via flexible fiberoptic endoscopy. Am. J. Infect. Control 1996;24:396-401.
  61. Sattar SA, Springthorpe VS. Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev. Infect. Dis. 1991;13:430-47.
  62. Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986;255:1887-91.
  63. Weber DJ, Barbee SL, Sobsey MD, Rutala WA. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound. Infect. Control Hosp. Epidemiol. 1999;20:821-7.
  64. Rice EW, Clark RM, Johnson CH. Chlorine inactivation of Escherichia coli O157:H7. Emerg. Infect. Dis. 1999;5:461-3.
  65. Pentella MA, Fisher T, Chandler S, Britt-Ohrmund T, Kwa BH, Yangco BG. Are disinfectants accurately prepared for use in hospital patient care areas? Infect. Control Hosp. Epidemiol. 2000;21:103.
  66. Bhalla A, Pultz NJ, Gries DM, et al. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004;25:164-7.
  67. Ray AJ, Hoyen CK, Taub TF, Eckstein EC, Donskey CJ. Nosocomial transmission of vancomycin-resistant enterococci from surfaces. JAMA 2002;287:1400-1.
  68. Westwood JC, Mitchell MA, Legace S. Hospital sanitation: the massive bacterial contamination of the wet mop. Appl. Microbiol. 1971;21:693-7.
  69. Rutala WA, Weber DJ. Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection. Infect. Control Hosp. Epidemiol. 1999;20:69-76.
  70. Russell AD. Bacterial spores and chemical sporicidal agents. Clin. Microbiol. Rev. 1990;3:99-119.
  71. Terleckyj B, Axler DA. Quantitative neutralization assay of fungicidal activity of disinfectants. Antimicrob. Agents Chemother. 1987;31:794-8.
  72. Klein M, DeForest A. The inactivation of viruses by germicides. Chem. Specialists Manuf. Assoc. Proc. 1963;49:116-8.
  73. Rutala WA, Cole EC, Wannamaker NS, Weber DJ. Inactivation of Mycobacterium tuberculosis and Mycobacterium bovis by 14 hospital disinfectants. Am. J. Med. 1991;91:267S-271S.
  74. Robison RA, Bodily HL, Robinson DF, Christensen RP. A suspension method to determine reuse life of chemical disinfectants during clinical use. Appl. Environ. Microbiol. 1988;54:158-64.
  75. Isenberg HD, Giugliano ER, France K, Alperstein P. Evaluation of three disinfectants after in-use stress. J.Hosp. Infect. 1988;11:278-85.
  76. Cole EC, Rutala WA, Nessen L, Wannamaker NS, Weber DJ. Effect of methodology, dilution, and exposure time on the tuberculocidal activity of glutaraldehyde-based disinfectants. Appl. Environ. Microbiol. 1990;56:1813-7.
  77. Power EG, Russell AD. Sporicidal action of alkaline glutaraldehyde: factors influencing activity and a comparison with other aldehydes. J. Appl. Bacteriol. 1990;69:261-8.
  78. Rutala WA, Gergen MF, Weber DJ. Sporicidal activity of chemical sterilants used in hospitals. Infect. Control Hosp. Epidemiol. 1993;14:713-8.
  79. Rutala WA, Gergen MF, Weber DJ. Inactivation of Clostridium difficile spores by disinfectants. Infect. Control Hosp. Epidemiol. 1993;14:36-9.
  80. Ascenzi JM, Ezzell RJ, Wendt TM. A more accurate method for measurement of tuberculocidal activity of disinfectants. Appl. Environ. Microbiol. 1987;53:2189-92.
  81. Collins FM. Use of membrane filters for measurement of mycobactericidal activity of alkaline glutaraldehyde solution. Appl. Environ. Microbiol. 1987;53:737-9.
  82. Rubbo SD, Gardner JF, Webb RL. Biocidal activities of glutaraldehyde and related compounds. J. Appl. Bacteriol. 1967;30:78-87.
  83. Rutala WA, Weber DJ. FDA labeling requirements for disinfection of endoscopes: a counterpoint. Infect. Control Hosp. Epidemiol. 1995;16:231-5.
  84. Collins FM. Kinetics of the tuberculocidal response by alkaline glutaraldehyde in solution and on an inert surface. J. Appl. Bacteriol. 1986;61:87-93.
  85. Food and Drug Administration. 2005. FDA-cleared sterilants and high-level disinfectants with general claims for processing reusable medical and dental devices, May 13, 2005. www.fda.gov/cdrh/ode/germlab.html.
  86. Crow S, Metcalf RW, Beck WC, Birnbaum D. Disinfection or sterilization? Four views on arthroscopes. AORN J. 1983;37:854-9, 862-8.
  87. Loffer FD. Disinfection vs. sterilization of gynecologic laparoscopy equipment. The experience of the Phoenix Surgicenter. J. Reprod. Med. 1980;25:263-6.
  88. Johnson LL, Shneider DA, Austin MD, Goodman FG, Bullock JM, DeBruin JA. Two per cent glutaraldehyde: a disinfectant in arthroscopy and arthroscopic surgery. J. Bone Joint Surg. 1982;64:237-9.
  89. Burns S, Edwards M, Jennings J, et al. Impact of variation in reprocessing invasive fiberoptic scopes on patient outcomes. Infect. Control Hosp. Epidemiol. 1996;17(suppl):P42.
  90. Fuselier HA, Jr., Mason C. Liquid sterilization versus high level disinfection in the urologic office. Urology 1997;50:337-40.
  91. Muscarella LF. High-level disinfection or "sterilization" of endoscopes? Infect. Control Hosp. Epidemiol. 1996;17:183-7.
  92. Miles RS. What standards should we use for the disinfection of large equipment? J. Hosp. Infect. 1991;18:264-73.
  93. Lee RM, Kozarek RA, Sumida SE, Raltz SL. Risk of contamination of sterile biopsy forceps in disinfected endoscopes. Gastrointest. Endosc. 1998;47:377-81.
  94. Kinney TP, Kozarek RA, Raltz S, Attia F. Contamination of single-use biopsy forceps: A prospective in vitro analysis. Gastrointest. Endosc. 2002;56:209-12.
  95. Centers for Disease Control. Recommendations for preventing possible transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from tears. MMWR 1985;34:533-4.
  96. Lettau LA, Bond WW, McDougal JS. Hepatitis and diaphragm fitting. JAMA 1985;254:752.
  97. Schembre DB. Infectious complications associated with gastrointestinal endoscopy. Gastrointest. Endosc. Clin. N. Am. 2000;10:215-32.
  98. Nelson DB. Infectious disease complications of GI endoscopy: Part II, exogenous infections. Gastrointest. Endosc. 2003;57:695-711.
  99. Chu NS, Favero M. The microbial flora of the gastrointestinal tract and the cleaning of flexible endoscopes. Gastrointest. Endosc. Clin. N. Am. 2000;10:233-44.
  100. Alfa MJ, Sitter DL. In-hospital evaluation of orthophthalaldehyde as a high level disinfectant for flexible endoscopes. J. Hosp. Infect. 1994;26:15-26.
  101. Vesley D, Melson J, Stanley P. Microbial bioburden in endoscope reprocessing and an in-use evaluation of the high-level disinfection capabilities of Cidex PA. Gastroenterol. Nurs. 1999;22:63-8.
  102. Chu NS, McAlister D, Antonoplos PA. Natural bioburden levels detected on flexible gastrointestinal endoscopes after clinical use and manual cleaning. Gastrointest. Endosc. 1998;48:137-42.
  103. Rutala WA, Weber DJ. Reprocessing endoscopes: United States perspective. J. Hosp. Infect. 2004;56:S27-S39.
  104. Hanson PJ, Gor D, Clarke JR, et al. Contamination of endoscopes used in AIDS patients. Lancet 1989;2:86-8.
  105. Hanson PJ, Gor D, Clarke JR, et al. Recovery of the human immunodeficiency virus from fibreoptic bronchoscopes. Thorax 1991;46:410-2.
  106. Chaufour X, Deva AK, Vickery K, et al. Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model. J. Vasc. Surg. 1999;30:277-82.
  107. Cheung RJ, Ortiz D, DiMarino AJ, Jr. GI endoscopic reprocessing practices in the United States. Gastrointest. Endosc. 1999;50:362-8.
  108. American Society for Gastrointestinal Endoscopy. Position statement: reprocessing of flexible gastrointestinal endoscopes. Gastrointest. Endosc. 1996;43:541-6.
  109. Food and Drug Administration. Content and format of premarket notification [510(k)] submissions for liquid chemical sterilants/high level disinfectants. www.fda.gov/cdrh/ode/397 2000.
  110. Urayama S, Kozarek RA, Sumida S, Raltz S, Merriam L, Pethigal P. Mycobacteria and glutaraldehyde: is high-level disinfection of endoscopes possible? Gastrointest. Endosc. 1996;43:451-6.
  111. Jackson J, Leggett JE, Wilson DA, Gilbert DN. Mycobacterium gordonae in fiberoptic bronchoscopes. Am. J. Infect. Control 1996;24:19-23.
  112. Martiny H, Floss H, Zuhlsdorf B. The importance of cleaning for the overall results of processing endoscopes. J. Hosp. Infect. 2004;56:S16-S22.
  113. Alvarado CJ, Reichelderfer M. APIC guideline for infection prevention and control in flexible endoscopy. Association for Professionals in Infection Control. Am. J. Infect. Control 2000;28:138-55.
  114. Society of Gastroenterology Nurses and Associates. Guideline for the use of high-level disinfectants and sterilants for reprocessing of flexible gastrointestinal endoscopes. Gastroenterol. Nurs. 2000;23:180-7.
  115. Society of Gastroenterology Nurses and Associates. Standards of infection control in reprocessing of flexible gastrointestinal endoscopes. Gastroenterol. Nurs. 2006;29:142-8.
  116. Nelson DB, Jarvis WR, Rutala WA, et al. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Infect Control Hosp Epidemiol 2003;24:532-537.
  117. Martin MA, Reichelderfer M, 1991, and 1993 APIC Guidelines Committee. APIC guidelines for infection prevention and control in flexible endoscopy. Am. J. Infect. Control 1994;22:19-38.
  118. Rey JF, Halfon P, Feryn JM, Khiri H, Masseyeff MF, Ouzan D. Risk of transmission of hepatitis C virus by digestive endoscopy. Gastroenterol. Clin. Biol. 1995;19:346-9.
  119. Cronmiller JR, Nelson DK, Jackson DK, Kim CH. Efficacy of conventional endoscopic disinfection and sterilization methods against Helicobacter pylori contamination. Helicobacter 1999;4:198-203.
  120. Sartor C, Charrel RN, de Lamballerie X, Sambuc R, De Micco P, Boubli L. Evaluation of a disinfection procedure for hysteroscopes contaminated by hepatitis C virus. Infect. Control Hosp. Epidemiol. 1999;20:434-6.
  121. Hanson PJ, Chadwick MV, Gaya H, Collins JV. A study of glutaraldehyde disinfection of fibreoptic bronchoscopes experimentally contaminated with Mycobacterium tuberculosis. J. Hosp. Infect. 1992;22:137-42.
  122. Merighi A, Contato E, Scagliarini R, et al. Quality improvement in gastrointestinal endoscopy: microbiologic surveillance of disinfection. Gastrointest. Endosc. 1996;43:457-62.
  123. Bond WW. Endoscope reprocessing: Problems and solutions. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:151-163.
  124. Deva AK, Vickery K, Zou J, West RH, Harris JP, Cossart YE. Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model. J. Hosp. Infect. 1996;33:119-30.
  125. Hanson PJ, Gor D, Jeffries DJ, Collins JV. Elimination of high titre HIV from fibreoptic endoscopes. Gut 1990;31:657-9.
  126. Wu MS, Wang JT, Yang JC, et al. Effective reduction of Helicobacter pylori infection after upper gastrointestinal endoscopy by mechanical washing of the endoscope. Hepatogastroenterology. 1996;43:1660-4.
  127. Kirschke DL, Jones TF, Craig AS, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N. Engl. J. Med. 2003;348:214-20.
  128. Srinivasan A, Wolfenden LL, Song X, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N. Engl. J. Med. 2003;348:221-7.
  129. Kaczmarek RG, Moore RM, Jr., McCrohan J, et al. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am. J. Med. 1992;92:257-61.
  130. Bradley CR, Babb JR. Endoscope decontamination: automated vs. manual. J. Hosp. Infect. 1995;30:537-42.
  131. Muscarella LF. Advantages and limitations of automatic flexible endoscope reprocessors. Am. J. Infect. Control 1996;24:304-9.
  132. Muscarella LF. Automatic flexible endoscope reprocessors. Gastrointest. Endosc. Clin. N. Am. 2000;10:245-57.
  133. Alvarado CJ, Stolz SM, Maki DG. Nosocomial infections from contaminated endoscopes: a flawed automated endoscope washer. An investigation using molecular epidemiology. Am. J. Med. 1991;91:272S-280S.
  134. Fraser VJ, Jones M, Murray PR, Medoff G, Zhang Y, Wallace RJ, Jr. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am. Rev. Respir. Dis. 1992;145:853-5.
  135. Cooke RP, Whymant-Morris A, Umasankar RS, Goddard SV. Bacteria-free water for automatic washer-disinfectors: an impossible dream? J. Hosp. Infect. 1998;39:63-5.
  136. Muscarella LF. Deja Vu...All over again? The importance of instrument drying. Infect. Control Hosp. Epidemiol. 2000;21:628-9.
  137. Rutala WA, Weber DJ. Importance of lumen flow in liquid chemical sterilization. Am. J. Infect. Control 1999;20:458-9.
  138. Dwyer DM, Klein EG, Istre GR, Robinson MG, Neumann DA, McCoy GA. Salmonella newport infections transmitted by fiberoptic colonoscopy. Gastrointest. Endosc. 1987;33:84-7.
  139. Wheeler PW, Lancaster D, Kaiser AB. Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J. Infect. Dis. 1989;159:954-8.
  140. Bond WW. Virus transmission via fiberoptic endoscope: recommended disinfection. JAMA 1987;257:843-4.
  141. Lynch DA, Porter C, Murphy L, Axon AT. Evaluation of four commercial automatic endoscope washing machines. Endoscopy 1992;24:766-70.
  142. Bond WW. Disinfection and endoscopy: microbial considerations. J. Gastroenterol. Hepatol. 1991;6:31-6.
  143. Nelson D. Newer technologies for endoscope disinfection: electrolyzed acid water and disposable-component endoscope systems. Gastrointest. Endosc. Clin. N. Am. 2000;10:319-28.
  144. Silberman HD. Non-inflatable sterile sheath for introduction of the flexible nasopharyngolaryngoscope. Ann Otol, Rhinol, Laryngol 2001;110:385-7.
  145. Kruse A, Rey JF. Guidelines on cleaning and disinfection in GI endoscopy. Update 1999. The European Society of Gastrointestinal Endoscopy. Endoscopy 2000;32:77-80.
  146. British Thoracic Society. British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax 2001;56:1-21.
  147. Association of Operating Room Nurses. Recommended practices for use and care of endoscopes. 2000 standards, recommended practices, and guidelines. Denver, CO: AORN, 2000:243-7.
  148. British Society of Gastroenterology. Cleaning and disinfection of equipment for gastrointestinal endoscopy. Report of a working party of the British Society of Gastroenterology Endoscope Committee. Gut 1998;42:585-93.
  149. Jackson FW, Ball MD. Correction of deficiencies in flexible fiberoptic sigmoidoscope cleaning and disinfection technique in family practice and internal medicine offices. Arch. Fam. Med. 1997;6:578-82. v
  150. Orsi GB, Filocamo A, Di Stefano L, Tittobello A. Italian National Survey of Digestive Endoscopy Disinfection Procedures. Endoscopy 1997;29:732-8; quiz 739-40.
  151. Honeybourne D, Neumann CS. An audit of bronchoscopy practice in the United Kingdom: a survey of adherence to national guidelines. Thorax 1997;52:709-13.
  152. Michele TM, Cronin WA, Graham NM, et al. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting. JAMA 1997;278:1093-5.
  153. Bronowicki JP, Venard V, Botte C, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N. Engl. J. Med. 1997;337:237-40.
  154. Agerton T, Valway S, Gore B, et al. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. JAMA 1997;278:1073-7.
  155. Food and Drug Administration, Centers for Disease Control and Prevention. FDA and CDC public health advisory: Infections from endoscopes inadequately reprocessed by an automated endoscope reprocessing system, Food and Drug Administration, Rockville, MD. 1999.
  156. Nelson DB, Muscarella LF. Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy. World J Gastroenterol 2006;12:3953-64.
  157. Riley R, Beanland C, Bos H. Establishing the shelf life of flexible colonoscopes. Gastroenterol. Nurs. 2002;25:114-9.
  158. Rejchrt S, Cermak P, Pavlatova L, Mickova E, Bures J. Bacteriologic testing of endoscopes after high-level disinfection. Gastrointest. Endosc. 2004;60:76-8.
  159. Willis C. Bacteria-free endoscopy rinse water - a realistic aim? Epidemiol. Infect. 2005;134:279-84.
  160. Humphreys H, McGrath H, McCormick PA, Walsh C. Quality of final rinse water used in washer-disinfectors for endoscopes. J. Hosp. Infect. 2002;51:151-3.
  161. Pang J, Perry P, Ross A, Forbes GM. Bacteria-free rinse water for endoscope disinfection. Gastrointest. Endosc. 2002;56:402-6.
  162. Leung J, Vallero R, Wilson R. Surveillance cultures to monitor quality of gastrointestinal endoscope reprocessing. Am. J. Gastroenterol. 2003;98.
  163. Moses FM, Lee J. Surveillance cultures to monitor quality of gastrointestinal endoscope reprocessing. Am. J. Gastroenterol. 2003;98:77-81.
  164. Tunuguntla A, Sullivan MJ. Monitoring quality of flexible endoscopic disinfection by microbiologic surveillance cultures. Tennessee Med 2004;October:453-6.
  165. Muscarella LF. Application of environmental sampling to flexible endoscope reprocessing: The importance of monitoring the rinse water. Infect . Control Hosp. Epidemiol. 2002;23:285-9.
  166. Fraser TG, Reiner S, Malcznski M, Yarnold PR, Warren J, Noskin GA. Multidrug-resistant Pseudomonas aeruginosa cholangiopancreatography: Failure of routine endoscope cultures to prevent an outbreak. Infect Control Hosp Epidemiol 2004;25:856-9.
  167. Bond WW, Hedrick ER. Microbiological culturing of environmental and medical-device surfaces. In: Isenberg HD, and M.J.R. Gilchrist, ed. Clinical Microbiology Procedures Handbook, Section 11, Epidemiologic and Infection Control Microbiology. Washington, DC: American Society for Microbiology, 1992:11.10.1-11.10.9.
  168. Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH. Manual of Clinical Microbiology. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH, eds. Washington, D.C.: American Society for Microbiology Press, 2003.
  169. Blob R, Kampf G. Test models to determine cleaning efficacy with different types of bioburden and its clinical correlation. J. Hosp. Infect. 2004;56 (suppl):S44-S48.
  170. Obee PC, Griffith CJ, Cooper RA, Cooke RP, Bennion NE, Lewis M. Real-time monitoring in managing the decontamination of flexible gastrointestinal endoscopes. Am. J. Infect. Control 2005;33:202-6.
  171. Sciortino CV, Xia EL, Mozee A. Assessment of a novel approach to evaluate the outcome of endoscope reprocessing. Infect Control Hosp Epidemiol 2004;25:284-90.
  172. Murphy C. Inactivated glutaraldehyde: Lessons for infection control. Am. J. Infect. Control 1998;26:159-60.
  173. Carsauw H, Debacker N. Recall of patients after use of inactive batch of Cidex disinfection solution in Belgian hospitals, Fifth International Conference of the Hospital Infection Society, Edinburgh, September 15-18, 2002. Hospital Infections Society.
  174. Ad hoc Committee on Infection Control in the Handling of Endoscopic Equipment. Guidelines for preparation of laparoscopic instrumentation. AORN J. 1980;32:65-6, 70, 74, 76.
  175. Taylor EW, Mehtar S, Cowan RE, Feneley RC. Endoscopy: disinfectants and health. Report of a meeting held at the Royal College of Surgeons of England, February 1993. J. Hosp. Infect. 1994;28:5-14.
  176. Hulka JF, Wisler MG, Bruch C. A discussion: laparoscopic instrument sterilization. Med. Instrum. 1977;11:122-3.
  177. Corson SL, Block S, Mintz C, Dole M, Wainwright A. Sterilization of laparoscopes. Is soaking sufficient? J. Reprod. Med. 1979;23:49-56.
  178. Corson SL, Dole M, Kraus R, Richards L, Logan B. Studies in sterilization of the laparoscope: II. J. Reprod. Med. 1979;23:57-9.
  179. Chan-Myers H, McAlister D, Antonoplos P. Natural bioburden levels detected on rigid lumened medical devices before and after cleaning. Am. J. Infect. Control 1997;25:471-6.
  180. Rodrigues C, Mehta AC, Jha U, Bharucha M, Dastur FD, Udwadia TE. Nosocomial Mycobacterium chelonae infection in laparoscopic surgery. Infect . Control Hosp. Epidemiol. 2001;22:474-5.
  181. Marshburn PB, Rutala WA, Wannamaker NS, Hulka JF. Gas and steam sterilization of assembled versus disassembled laparoscopic equipment. Microbiologic studies. J. Reprod. Med. 1991;36:483-7.
  182. Bernhang AM. Clostridium pyoarthrosis following arthroscopy. Arthroscopy 1987;3:56-8.
  183. D'Angelo GL, Ogilvie-Harris DJ. Septic arthritis following arthroscopy, with cost/benefit analysis of antibiotic prophylaxis. Arthroscopy 1988;4:10-4.
  184. Weber DJ, Rutala WA. Nosocomial ocular infections. In: Mayhall CG, ed. Infect. Control and Hosp. Epidemiol. Philadelphia: Lippincott Williams & Wilkins, 1999:287-99.
  185. Rutala WA, Peacock JE, Gergen MF, Sobsey MD, Weber DJ. Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities. Antimicrob. Agents Chemother. 2006;50:1419-24.
  186. Sattar SA, Springthorpe VS, Karim Y, Loro P. Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol. Infect. 1989;102:493-505.
  187. Chronister CL. Structural damage to Schiotz tonometers after disinfection with solutions. Optom. Vis. Sci. 1997;74:164-6.
  188. Nagington J, Sutehall GM, Whipp P. Tonometer disinfection and viruses. Br. J. Ophthalmol. 1983;67:674-6.
  189. Craven ER, Butler SL, McCulley JP, Luby JP. Applanation tonometer tip sterilization for adenovirus type 8. Ophthalmology 1987;94:1538-40.
  190. American Academy of Ophthalmology. Updated recommendations for ophthalmic practice in relation to the human immunodeficiency virus. American Academy of Ophthalmology, San Francisco, CA, 1988.
  191. Pepose JS, Linette G, Lee SF, MacRae S. Disinfection of Goldmann tonometers against human immunodeficiency virus type 1. Arch. Ophthalmol. 1989;107:983-5.
  192. Ventura LM, Dix RD. Viability of herpes simplex virus type 1 on the applanation tonometer. Am. J. Ophthalmol. 1987;103:48-52.
  193. Koo D, Bouvier B, Wesley M, Courtright P, Reingold A. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments. Infect. Control Hosp. Epidemiol. 1989;10:547-52.
  194. Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J. Infect. Dis. 1993;167:1307-13.
  195. Fritz S, Hust MH, Ochs C, Gratwohl I, Staiger M, Braun B. Use of a latex cover sheath for transesophageal echocardiography (TEE) instead of regular disinfection of the echoscope? Clin. Cardiol. 1993;16:737-40.
  196. Lawrentschuk N, Chamberlain M. Sterile disposable sheath sytsem for flexible cytoscopes. Urology 2005;66:1310-3.
  197. Milki AA, Fisch JD. Vaginal ultrasound probe cover leakage: implications for patient care. Fertil. Steril. 1998;69:409-11.
  198. Storment JM, Monga M, Blanco JD. Ineffectiveness of latex condoms in preventing contamination of the transvaginal ultrasound transducer head. South. Med. J. 1997;90:206-8.
  199. Hignett M, Claman P. High rates of perforation are found in endovaginal ultrasound probe covers before and after oocyte retrieval for in vitro fertilization-embryo transfer. J. Assist. Reprod. Genet. 1995;12:606-9.
  200. Amis S, Ruddy M, Kibbler CC, Economides DL, MacLean AB. Assessment of condoms as probe covers for transvaginal sonography. J. Clin. Ultrasound 2000;28:295-8.
  201. Rooks VJ, Yancey MK, Elg SA, Brueske L. Comparison of probe sheaths for endovaginal sonography. Obstet. Gynecol. 1996;87:27-9.
  202. Odwin CS, Fleischer AC, Kepple DM, Chiang DT. Probe covers and disinfectants for transvaginal transducers. J. Diagnostic Med. Sonography 1990;6:130-5.
  203. Benson WG. Exposure to glutaraldehyde. J. Soc. Occup. Med. 1984;34:63-4.
  204. Garland SM, de Crespigny L. Prevention of infection in obstetrical and gynaecological ultrasound practice. Aust. N. Z. J. Obstet Gynaecol. 1996;36:392-5.
  205. Fowler C, McCracken D. US probes: risk of cross infection and ways to reduce it--comparison of cleaning methods. Radiology 1999;213:299-300.
  206. Muradali D, Gold WL, Phillips A, Wilson S. Can ultrasound probes and coupling gel be a source of nosocomial infection in patients undergoing sonography? An in vivo and in vitro study. AJR. Am. J. Roentgenol. 1995;164:1521-4.
  207. Lewis DL, Arens M, Appleton SS, et al. Cross-contamination potential with dental equipment. Lancet 1992;340:1252-4.
  208. Lewis DL, Boe RK. Cross-infection risks associated with current procedures for using high-speed dental handpieces. J. Clin. Microbiol. 1992;30:401-6.
  209. American Dental Association. Infection control recommendations for the dental office and the dental laboratory. JADA 1996;127:672-80.
  210. Centers for Disease Control. Recommended Infection-Control Practices for Dentistry, 1993. MMWR 1993;41:1-12.
  211. Department of Health and Human Services. Food and Drug Administration. Dental handpiece sterilization, Food and Drug Administration, Rockville, MD, 1992.
  212. Silverstone SE, Hill DE. Evaluation of sterilization of dental handpieces by heating in synthetic compressor lubricant. Gen. Dent. 1999;47:158-60.
  213. Goodman HS, Carpenter RD, Cox MR. Sterilization of dental instruments and devices: an update. Am. J. Infect. Control 1994;22:90-4.
  214. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. Fed. Regist. 1991;56:64003-182.
  215. Occupational Safety and Health Administration. OSHA Memorandum from Stephen Mallinger. EPA-registered disinfectants for HIV/HBV. Washington, DC, 1997.
  216. Gurevich I, Dubin R, Cunha BA. Dental instrument and device sterilization and disinfection practices. J. Hosp. Infect. 1996;32:295-304.
  217. Smith A, Dickson M, Aitken J, Bagg J. Contaminated dental instruments. J. Hosp. Infect. 2002;51:233-5.
  218. Hastreiter RJ, Molinari JA, Falken MC, Roesch MH, Gleason MJ, Merchant VA. Effectiveness of dental office instrument sterilization procedures. J. Am. Dent. Assoc. 1991;122:51-6.
  219. Andres MT, Tejerina JM, Fierro JF. Reliability of biologic indicators in a mail-return sterilization-monitoring service: a review of 3 years. Quintessence Int. 1995;26:865-70.
  220. Miller CH, Sheldrake MA. The ability of biological indicators to detect sterilization failures. Am. J. Dent. 1994;7:95-7.
  221. Sarin PS, Scheer DI, Kross RD. Inactivation of human T-cell lymphotropic retrovirus (HTLV-III) by LD. N. Engl. J. Med. 1985;313:1416.
  222. Sarin PS, Scheer DI, Kross RD. Inactivation of human T-cell lymphotropic retrovirus. Environ Microbiol 1990;56:1423-8.
  223. Ascenzi JM. Standardization of tuberculocidal testing of disinfectants. J. Hosp. Infect. 1991;18:256-63.
  224. Bond WW, Favero MS, Petersen NJ, Ebert JW. Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J. Clin. Microbiol. 1983;18:535-8.
  225. Kobayashi H, Tsuzuki M. The effect of disinfectants and heat on hepatitis B virus. J. Hosp. Infect. 1984;5:93-4.
  226. Spire B, Barre-Sinoussi F, Montagnier L, Chermann JC. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet 1984;2:899-901.
  227. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. J. Infect. Dis. 1985;152:400-3.
  228. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36:S3-S18.
  229. . Prince DL, Prince HN, Thraenhart O, Muchmore E, Bonder E, Pugh J. Methodological approaches to disinfection of human hepatitis B virus. J. Clin. Microbiol. 1993;31:3296-304.
  230. Prince DL, Prince RN, Prince HN. Inactivation of human immunodeficiency virus type 1 and herpes simplex virus type 2 by commercial hospital disinfectants. Chemical Times and Trends 1990;13:13-16.
  231. Sattar SA, Springthorpe VS, Conway B, Xu Y. Inactivation of the human immunodeficiency virus: an update. Rev. Med. Microbiol. 1994;5:139-150.
  232. Kaplan JC, Crawford DC, Durno AG, Schooley RT. Inactivation of human immunodeficiency virus by Betadine. Infect. Control 1987;8:412-4.
  233. Hanson PJ, Gor D, Jeffries DJ, Collins JV. Chemical inactivation of HIV on surfaces. Br. Med. J. 1989;298:862-4.
  234. Hanson PJ, Jeffries DJ, Collins JV. Viral transmission and fibreoptic endoscopy. J. Hosp. Infect. 1991;18:136-40.
  235. Payan C, Cottin J, Lemarie C, Ramont C. Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectants assessed by a modified HepG2 cell culture. J. Hosp. Infect. 2001;47:282-87.
  236. Chanzy B, Duc-Bin DL, Rousset B, et al. Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest. Endosc. 1999;50:147-51.
  237. Druce JD, Russell JS, Birch CJ, Yates LA, Harper RW, Smolich JJ. A decontamination and sterilization protocol employed during reuse of cardiac electrophysiology catheters inactivates human immunodeficiency virus. Infect. Control Hosp. Epidemiol. 2003;24:184-90.
  238. Payan C, Pivert A, Kampf G, Ramont C, Cottin J, Lemarie C. Assessment of new chemical disinfectants for HBV virucidal activity in a cell culture model. J. Hosp. Infect. 2004;56 (suppl):S58-S63.
  239. Reynolds CD, Rhinehart E, Dreyer P, Goldmann DA. Variability in reprocessing policies and procedures for flexible fiberoptic endoscopes in Massachusetts hospitals. Am. J. Infect. Control 1992;20:283-90.
  240. Handsfield HH, Cummings MJ, Swenson PD. Prevalence of antibody to human immunodeficiency virus and hepatitis B surface antigen in blood samples submitted to a hospital laboratory. Implications for handling specimens. JAMA 1987;258:3395-7.
  241. Baker JL, Kelen GD, Sivertson KT, Quinn TC. Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA 1987;257:2609-11.
  242. Kelen GD, Fritz S, Qaqish B, et al. Unrecognized human immunodeficiency virus infection in emergency department patients. N. Engl. J. Med. 1988;318:1645-50.
  243. Ishino Y, Ido K, Sugano K. Contamination with hepatitis B virus DNA in gastrointestinal endoscope channels: Risk of infection on reuse after on-site cleaning. Endoscopy 2005;37:548-51.
  244. Agolini G, Russo A, Clementi M. Effect of phenolic and chlorine disinfectants on hepatitis C virus binding and infectivity. Am. J. Infect. Control 1999;27:236-9.
  245. Alter MJ, Tokars JI, Arduino MJ, Favero MS. Nosocomial infections with hemodialysis. In: Mayhall CG, ed. Infect. Control and Hosp. Epidemiol. Philadelphia: Lippincott Williams & Wilkins, 2004:1139-60.
  246. Centers for Disease Control. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR. 2001;50:1-43.
  247. Velandia M, Fridkin SK, Cardenas V, et al. Transmission of HIV in dialysis centre. Lancet 1995;345:1417-22.
  248. Guinto CH, Bottone EJ, Raffalli JT, Montecalvo MA, Wormser GP. Evaluation of dedicated stethoscopes as a potential source of nosocomial pathogens. Am. J. Infect. Control 2002;30:499-502.
  249. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 1997. Semin. Dialysis 2000;13:75-85.
  250. Amato RL, Curtis JM. The practical application of ozone in dialysis. Nephrol. News Issues 2002;September 27-9.
  251. Smeets E, Koonman J, van der Sande F, et al. Prevention of biofilm formation in dialysis water treatment systems. Kidney Int. 2003;63:1574-6.
  252. Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dialysis 2005;18:52-61.
  253. Association for the Advancement of Medical Instrumentation. Reuse of hemodialyzers: Association for the Advancement of Medical Instrumentation, Arlington VA, 2002/2003:ANSI/AAMI RD47:2002 & RD47:2002/A1:2003; 1-32.
  254. Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J. Infect. Dis. 1981;143:42-50.
  255. Skoutelis AT, Westenfelder GO, Beckerdite M, Phair JP. Hospital carpeting and epidemiology of Clostridium difficile. Am. J. Infect. Control 1994;22:212-7.
  256. Wilcox MH, Fawley WN. Hospital disinfectants and spore formation by Clostridium difficile. Lancet 2000;356:1324.
  257. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am. J. Epidemiol. 1988;127:1289-94.
  258. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J. Hosp. Infect. 2003;54:109-14.
  259. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin. Infect. Dis. 2000;31:995-1000.
  260. Marler LM, Siders JA, Wolters LC, Pettigrew Y, Skitt BL, Allen SD. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J. Clin. Microbiol. 1992;30:514-6.
  261. Brazier JG. The diagnosis of Clostridium difficile-associated disease. J. Antimicrob. Chemother. 1998;41 (suppl):29-40.
  262. Perez J, Springthorpe S, Sattar SA. Activity of selected oxidizing microbicides against spores of Clostridium difficile: Relevance to environmental control. Am. J. Infect. Control 2005;33:320-5.
  263. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 1989;320:204-10.
  264. Jernigan JA, Siegman-Igra Y, Guerrant RC, Farr BM. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epidemiol 1998;19:494-9.
  265. Hughes CE, Gebhard RL, Peterson LR, Gerding DN. Efficacy of routine fiberoptic endoscope cleaning and disinfection for killing Clostridium difficile. Gastrointest. Endosc. 1986;32:7-9.
  266. Dyas A, Das BC. The activity of glutaraldehyde against Clostridium difficile. J. Hosp. Infect. 1985;6:41-5.
  267. Wullt M, Odenholt I, Walder M. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 2003;24:765-8.
  268. Block C. The effect of Perasafe and sodium dichloroisocyanurate (NaDCC) against spores of Clostridium difficile and Bacillus atrophaeus on stainless steel and polyvinyl chloride surfaces. J. Hosp. Infect. 2004;57:144-8.
  269. Occupational Safety and Health Administration. OSHA instruction CPL 2-2.44C. Office of Health Compliance Assistance. Washington, DC, 1992.
  270. Rutala WA, Weber DJ. Infection control: the role of disinfection and sterilization. J. Hosp. Infect. 1999;43:S43-55.
  271. Barbee SL, Weber DJ, Sobsey MD, Rutala WA. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization processes. Gastrointest. Endosc. 1999;49:605-11.
  272. Wilson JA, Margolin AB. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts. J. Hosp. Infect. 1999;42:231-7.
  273. Fayer R, Graczyk TK, Cranfield MR, Trout JM. Gaseous disinfection of Cryptosporidium parvum oocysts. Appl. Environ. Microbiol. 1996;62:3908-9.
  274. Venkitanarayanan KS, Ezeike GO, Hung YC, Doyle MP. Inactivation of Escherichia coli O157:H7 and Listeria monocytogenes on plastic kitchen cutting boards by electrolyzed oxidizing water. J. Food Prot. 1999;62:857-60.
  275. Taormina PJ, Beuchat LR. Behavior of enterohemorrhagic Escherichia coli O157:H7 on alfalfa sprouts during the sprouting process as influenced by treatments with various chemicals. J. Food Prot. 1999;62:850-6.
  276. Taormina PJ, Beuchat LR. Comparison of chemical treatments to eliminate enterohemorrhagic Escherichia coli O157:H7 on alfalfa seeds. J. Food Prot. 1999;62:318-24.
  277. Castillo A, Lucia LM, Kemp GK, Acuff GR. Reduction of Escherichia coli O157:H7 and Salmonella typhimurium on beef carcass surfaces using acidified sodium chlorite. J. Food Prot. 1999;62:580-4.
  278. Graham DY, Osato MS. Disinfection of biopsy forceps and culture of Helicobacter pylori from gastric mucosal biopsies. Am. J. Gastroenterol. 1999;94:1422-3.
  279. Kaneko H, Mitsuma T, Kotera H, Uchida K, Furusawa A, Morise K. Are routine cleaning methods sufficient to remove Helicobacter pylori from endoscopic equipment? Endoscopy 1993;25:435.
  280. Langenberg W, Rauws EA, Oudbier JH, Tytgat GN. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J. Infect. Dis. 1990;161:507-11.
  281. Miyaji H, Kohli Y, Azuma T, et al. Endoscopic cross-infection with Helicobacter pylori. Lancet 1995;345:464.
  282. Fantry GT, Zheng QX, James SP. Conventional cleaning and disinfection techniques eliminate the risk of endoscopic transmission of Helicobacter pylori. Am. J. Gastroenterol. 1995;90:227-32.
  283. Shimada T, Terano A, Ota S, Takikawa H, Sumino S. Risk of iatrogenic transmission of Helicobacter pylori by gastroscopes. Lancet 1996;347:1342-3.
  284. Roosendaal R, Kuipers EJ, van den Brule AJ, et al. Detection of Helicobacter pylori DNA by PCR in gastrointestinal equipment. Lancet 1993;341:900.
  285. Johnson CH, Rice EW, Reasoner DJ. Inactivation of Helicobacter pylori by chlorination. Appl. Environ. Microbiol. 1997;63:4969-70.
  286. Chapin M, Yatabe J, Cherry JD. An outbreak of rotavirus gastroenteritis on a pediatric unit. Am. J. Infect. Control 1983;11:88-91.
  287. Keswick BH, Pickering LK, DuPont HL, Woodward WE. Survival and detection of rotaviruses on environmental surfaces in day care centers. Appl. Environ. Microbiol. 1983;46:813-16.
  288. Ansari SA, Spingthorpe S, Sattar SA. Survival and vehicular spread of human rotaviruses: Possible relation to seasonality of outbreaks. Rev. Infect. Dis. 1991;13:448-61.
  289. Ansari SA, Sattar SA, Springthorpe VS, Wells GA, Tostowaryk W. Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces. J. Clin. Microbiol. 1988;26:1513-8.
  290. Sattar SA, Raphael RA, Lochnan H, Springthorpe VS. Rotavirus inactivation by chemical disinfectants and antiseptics used in hospitals. Can. J. Microbiol. 1983;29:1464-9.
  291. Lloyd-Evans N, Springthorpe VS, Sattar SA. Chemical disinfection of human rotavirus-contaminated inanimate surfaces. J. Hyg. (Lond). 1986;97:163-73.
  292. Tan JA, Schnagl RD. Inactivation of a rotavirus by disinfectants. Med. J. Aust. 1981;1:19-23.
  293. Sattar SA, Springthorpe VS, Karim Y, Loro P. Chemical disinfection of non-porous inanimate surfaces experimentally contaminated with four human pathogenic viruses. Epidemiol Infect 1989;102:493-505.
  294. Green J, Wright PA, Gallimore CI, Mitchell O, Morgan-Capner P, Brown DWG. The role of environmental contamination with small round structured viruses in a hospital outbreak investigated by reverse-transcriptase polymerase chain reaction assay. J. Hosp. Infect. 1998;39:39-45.
  295. Evans MR, Meldrum R, Lane W, et al. An outbreak of viral gastroenteritis following environmental contamination at a concert hall. Epidemiol & Infect 2002;129:355-360.
  296. Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO. A school outbreak of Norwalk-like virus: Evidence for airborne transmission. Epidemiol Infect 2003;131:727-36.
  297. Doultree JC, Druce JD, Birch CJ, Bowden DS, Marshall JA. Inactivation of feline calicivirus, a Norwalk virus surrogate. J. Hosp. Infect. 1999;41:51-7.
  298. Sattar SA. Microbicides and the environmental control of nosocomial viral infections. J. Hosp. Infect. 2004;56 (suppl):S64-S69.
  299. Jimenez L, Chiang M. Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: A surrogate for norovirus. Am. J. Infect. Control 2006;34:269-73.
  300. Gehrke C, Steinmann J, Goroncy-Bermes P. Inactivation of feline calicivirus, a surrogate of norovirus (formerly Norwalk-like viruses), by different types of alcohol in vitro and in vivo. J. Hosp. Infect. 2004;56:49-55.
  301. Centers for Disease Control and Prevention. Update: Severe acute respiratory syndrome - United States, May 14, 2003. MMWR 2003;52:436-8.
  302. Saknimit M, Inatsuki I, Sugiyama Y, Yagami K. Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu. 1988;37:341-5.
  303. Sizun J, Yu MW, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections. J. Hosp. Infect. 2000;46:55-60.
  304. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. Jpn. J. Vet. Res. 2004;52:105-12.
  305. Greub G, Raoult D. Biocides currently used for bronchoscope decontamination are poorly effective against free-living amoebae. Infect Control Hosp Epidemiol 2003;24:784-6.
  306. Leggiadro RJ. The threat of biological terrorism: A public health and infection control reality. Infect . Control Hosp. Epidemiol. 2000;21:53-6.
  307. Henderson DA. The looming threat of bioterrorism. Science 1999;283:1279-82.
  308. Centers for Disease Control. Biological and chemical terrorism: strategic plan for preparedness and response. MMWR 2000;49 (no. RR-4):1-14.
  309. Weber DJ, Rutala WA. Disinfection and sterilization of potential bioterrorism agents. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices and new research. Washington DC: Association for Professionals in Infection Control and Epidemiology, 2004:86-103.
  310. Ferrier A, Garin D, Crance JM. Rapid inactivation of vaccinia virus in suspension and dried on surfaces. J. Hosp. Infect. 2004;57:73-9.
  311. Butcher W, Ulaeto D. Contact inactivation of orthopoxviruses by household disinfectants. J. Appl. Microbiol. 2005;99:279-84.
  312. Brazis AR, Leslie JE, PW K, RL W. The inactivation of spores of Bacillus globigii and Bacillus anthracis by free available chlorine. Appl. Microbiol. 1958;6:338-342.
  313. Sattar SA, Springthorpe VS, Adegbunrin O. Is Bacillus subtilis (ATCC 19659) a suitable surrogate for evaluating microbicides against Bacillus anthracis., Association for Official Analytical Chemists International Annual Meeting, St. Louis, Missouri, 2004.
  314. Whitney EAS, Beatty ME, Taylor TH Jr, et al. Inactivation of Bacillus anthracis spores. Emerg. Infect. Dis. 2003;9:623-7.
  315. Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin. Infect. Dis. 2001;32:446-456.
  316. Chataigner D, Garnier R, Sans S, Efthymiou ML. [Acute accidental poisoning with hospital disinfectant. 45 cases of which 13 with fatal outcome]. Presse Med. 1991;20:741-3.
  317. Hess JA, Molinari JA, Gleason MJ, Radecki C. Epidermal toxicity of disinfectants. Am. J. Dent. 1991;4:51-6.
  318. Weber DJ, Rutala WA. Occupational risks associated with the use of selected disinfectants and sterilants. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:211-26.
  319. Cokendolpher JC, Haukos JF. The Practical Application of Disinfection and Sterilization in Health Care Facilities. Chicago: American Hospital Association, 1996.
  320. Rideout K, Teschke K, Dimich-Ward H, Kennedy SM. Considering risks to healthcare workers from glutaraldehyde alternatives in high-level dinfection. J. Hosp. Infect. 2005;59:4-11.
  321. Oie S, Kamiya A. Assessment of and intervention for the misuse of aldehyde disinfectants in Japan. Infect . Control Hosp. Epidemiol. 2002;23:98-9.
  322. American Conference of Governmental Industrial Hygienists (ACGIH). Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati: ACGIH, 2001.
  323. Jordan SLP, Russo MR, Blessing RL, Grab LA. Glutaraldehyde safety: inactivation and disposal. Abstract. Am. J. Infect. Control 1997;25:154-55.
  324. Jordan SL. The correct use of glutaraldehyde in the healthcare environment. Gastroenterol. Nurs. 1995;18:143-5.
  325. Cheung HY, Brown MR. Evaluation of glycine as an inactivator of glutaraldehyde. J Pharmacy Pharmacol 1982;34:211-4.
  326. Daschner F. The hospital and pollution: Role of the hospital epidemiologist in protecting the environment. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams and Wilkins, 1997:595-605.
  327. Rutala WA, Cole EC, Thomann CA, Weber DJ. Stability and bactericidal activity of chlorine solutions. Infect. Control Hosp. Epidemiol. 1998;19:323-7.
  328. Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin. Microbiol. Rev. 1997;10:597-610.
  329. Dychdala GR. Chlorine and chlorine compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:135-157.
  330. Rutala WA, Weber DJ. Principles of disinfecting patient-care items. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:133-49.
  331. Luebbert P. Home care. In: Pfeiffer JA, ed. APIC text of infection control and epidemiology. Vol. 1. Washington: Association for Professionals in Infection control and epidemiology, 2000:44-7.
  332. Parnes CA. Efficacy of sodium hypochlorite bleach and "alternative" products in preventing transfer of bacteria to and from inanimate surfaces. Environ. Health 1997;59:14-20.
  333. Karapinar M, Gonul SA. Effects of sodium bicarbonate, vinegar, acetic and citric acids on growth and survival of Yersinia enterocolitica. Int. J. Food Microbiol. 1992;16:343-7.
  334. McMurry LM, Oethinger M, Levy SB. Triclosan targets lipid synthesis. Nature 1998;394:531-2.
  335. Moken MC, McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob. Agents Chemother. 1997;41:2770-2.
  336. Scott E, Bloomfield SF, Barlow CG. An investigation of microbial contamination in the home. J. Hyg. (Lond). 1982;89:279-93.
  337. Rusin P, Orosz-Coughlin P, Gerba C. Reduction of faecal coliform, coliform and heterotrophic plate count bacteria in the household kitchen and bathroom by disinfection with hypochlorite cleaners. J. Appl. Microbiol. 1998;85:819-28.
  338. Gilbert P, McBain AJ. Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Reviews 2003;16:189-208.
  339. Bueumer R, Bloomfield SF, Exner M, Fara G, Scott EA. The need for a home hygiene policy and guidelines on home hygiene. Ann. Ig. 1999;11:11-26.
  340. International Scientific Forum on Home Hygiene. www.ifh-homehygiene.org.
  341. Russell AD, Russell NJ. Biocides: activity, action and resistance. In: Hunter PA, Darby GK, Russell NJ, eds. Fifty years of antimicrobials: past perspectives and future trends. England: Cambridge University Press, 1995:327-65.
  342. Russell AD. Bacterial resistance to disinfectants: Present knowledge and future problems. J. Hosp. Infect. 1998;43:S57-S68.
  343. Russell AD. Plasmids and bacterial resistance to biocides. J. Appl. Microbiol. 1997;83:155-65.
  344. Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J. Hosp. Infect. 1998;43:S57-68.
  345. Russell AD. Principles of antimicrobial activity and resistance. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:31-55.
  346. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin. Microbiol. Rev. 1999;12:147-79.
  347. Gerba CP, Rusin P. Relationship between the use of antiseptics/disinfectants and the development of antimicrobial resistance. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:187-94.
  348. Townsend DE, Ashdown N, Greed LC, Grubb WB. Transposition of gentamicin resistance to staphylococcal plasmids encoding resistance to cationic agents. J. Antimicrob. Chemother. 1984;14:115-24.
  349. Brumfitt W, Dixson S, Hamilton-Miller JM. Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet 1985;1:1442-3.
  350. Al-Masaudi SB, Day MJ, Russell AD. Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants. J. Appl. Bacteriol. 1988;65:329-37.
  351. Tennent JM, Lyon BR, Midgley M, Jones IG, Purewal AS, Skurray RA. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J. Gen. Microbiol. 1989;135:1-10.
  352. Kaulfers PM, Laufs R. [Transmissible formaldehyde resistance in Serratia marcescens]. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene - 1 - Abt - Originale B, Hygiene 1985;181:309-19.
  353. Tennent JM, Lyon BR, Gillespie MT, May JW, Skurray RA. Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichia coli. Antimicrob. Agents Chemother. 1985;27:79-83.
  354. Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect. Control Hosp. Epidemiol. 1997;18:417-21.
  355. Anderson RL, Carr JH, Bond WW, Favero MS. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect. Control Hosp. Epidemiol. 1997;18:195-9.
  356. Sakagami Y, Kajimura K. Bactericidal activities of disinfectants against vancomycin-resistant enterococci. J. Hosp. Infect. 2002;50:140-4.
  357. Sehulster LM, Anderson RL. Susceptibility of glycopeptide-intermediate resistant Staphylococcus aureus (GISA) to surface disinfectants, hand washing chemicals, and a skin antiseptic. Abstract Y-3. 98th General Meeting of American Society for Microbiology, May, 1998:547.
  358. Rutala WA, Weber DJ, Gergen MF. Studies on the disinfection of VRE-contaminated surfaces. Infect. Control Hosp. Epidemiol. 2000;21:548.
  359. Byers KE, Durbin LJ, Simonton BM, Anglim AM, Adal KA, Farr BM. Disinfection of hospital rooms contaminated with vancomycin-resistant Enterococcus faecium. Infect. Control Hosp. Epidemiol. 1998;19:261-4.
  360. Carling PC, Briggs JL, Perkins J, Highlander D. Improved cleaning of patient rooms using a new targeting method. Clin Inf Dis 2006;42:385-8.
  361. Russell AD, Suller MT, Maillard JY. Do antiseptics and disinfectants select for antibiotic resistance? J. Med. Microbiol. 1999;48:613-5.
  362. Russell AD. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. J. Hosp. Infect. 2004;57:97-104.
  363. Levy SB. The challenge of antibiotic resistance. Scientific Am. 1998;278:46-53.
  364. Jones RD, Jampani HB, Newman JL, Lee AS. Triclosan: a review of effectiveness and safety in health care settings. Am. J. Infect. Control 2000;28:184-96.
  365. Russell AD, McDonnell G. Concentration: a major factor in studying biocidal action. J. Hosp. Infect. 2000;44:1-3.
  366. Russell AD, Maillard JY. Reaction and response-relationship between antibiotic resistance and resistance to antiseptics and disinfectants. Am. J. Infect. Control 2000;28:204-6.
  367. Murtough SM, Hiom SJ, Palmer M, Russell AD. Biocide rotation in the healthcare setting: is there a case for policy implementation? J. Hosp. Infect. 2001;48:1-6.
  368. Murtough SM, Hiom SJ, Palmer M, Russell AD. A survey of rotational use of biocides in hospital pharmacy aseptic units. J. Hosp. Infect. 2002;50:228-31.
  369. Gebel J, Sonntag H-G, Werner H-P, Vavata V, Exner M, Kistemann T. The higher disinfectant resistance of nosocomial isolates of Klebsiella oxytoca: How reliable are indicator organisms in disinfectant testing? J. Hosp. Infect. 2002;50:309-11.
  370. Ruden H, Daschner F. Should we routinely disinfect floors? J. Hosp. Infect. 2002;51:309.
  371. Rutala WA, DJ W. Should we routinely disinfect floors? Reply to Professor F. Daschner. J. Hosp. Infect. 2002;51:309-11.
  372. Rutala WA, Weber DJ. The benefits of surface disinfection. Am. J. Infect. Control 2004;32:226-31.
  373. Dettenkofer M, Wenzler S, Amthor S, Antes G, Motschall E, Daschner FD. Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review. Am. J. Infect. Control 2004;32:84-9.
  374. Daschner F, Schuster A. Disinfection and the prevention of infectious disease-no adverse effects? Am. J. Infect. Control 2004;32:224-5.
  375. Cozad A, Jones RD. Disinfection and the prevention of infectious disease. Am. J. Infect. Control 2003;31:243-54.
  376. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1991:617-41.
  377. Rheinbaben FV, Schunemann S, Grob T, Wolff MH. Transmission of viruses via contact in a household setting: experiments using bacteriophage OX174 as a model virus. J. Hosp. Infect. 2000;46:61-66.
  378. Rutala WA, Weber DJ. Surface disinfection: should we do it? J. Hosp. Infect. 2001;48 (supplement A):S64-S68.
  379. Ayliffe GAJ, Collins DM, Lowbury EJL. Cleaning and disinfection of hospital floors. Brit. Med. J. 1966;2:442-5.
  380. Ayliffe GA, Collins BJ, Lowbury EJ, Babb JR, Lilly HA. Ward floors and other surfaces as reservoirs of hospital infection. J. Hyg. (Lond). 1967;65:515-36.
  381. Exner M, Vacata V, Hornei B, Dietlein E, Gebel J. Household cleaning and surface disinfection: New insights and strategies. J. Hosp. Infect. 2004;56 (suppl):S70-S75.
  382. Dharan S, Mourouga P, Copin P, Bessmer G, Tschanz B, Pittet D. Routine disinfection of patients' environmental surfaces. Myth or reality? J. Hosp. Infect. 1999;42:113-7.
  383. Engelhart S KL, Glasmacher A, Fischnaller E, Marklein G, Exner M. Pseudomonas aeruginosa outbreak in a haematology-oncology unit associated with contaminated surface cleaning equipment. J. Hosp. Infect. 2002;52:93-98.
  384. Denton M, Wilcox MH, Parnell P, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumanni on a neurosurgical intensive care unit. J. Hosp. Infect. 2004;56:106-10.
  385. Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces. J. Hosp. Infect. 2004;58:42-9.
  386. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol. 1996;17:53-80.
  387. Maki DG, Alvarado CJ, Hassemer CA, Zilz MA. Relation of the inanimate hospital environment to endemic nosocomial infection. N. Engl. J. Med. 1982;307:1562-6.
  388. Daschner F, Rabbenstein G, Langmaack H. [Surface decontamination in the control of hospital infections: comparison of different methods (author's transl)]. Dtsch. Med. Wochenschr. 1980;105:325-9.
  389. Danforth D, Nicolle LE, Hume K, Alfieri N, Sims H. Nosocomial infections on nursing units with floors cleaned with a disinfectant compared with detergent. J. Hosp. Infect. 1987;10:229-35.
  390. Smith TL, Iwen PC, Olson SB, Rupp ME. Environmental contamination with vancomycin-resistant enterococci in an outpatient setting. Infect. Control Hosp. Epidemiol. 1998;19:515-8.
  391. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect. Control Hosp. Epidemiol. 1997;18:622-7.
  392. Bonten MJM, Hayden MJ, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996;348:1615-9.
  393. Hardy KJ, Oppenheim BA, Gossain S, Gao F, Hawkey PM. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA. Infect Control Hosp Epidemiol 2006;27:127-32.
  394. Hota B. Contamination, disinfection, and cross-contamination: Are hospital surfaces reservoirs for nosocomial infection? Clin. Infect. Dis. 2004;39:1182-9.
  395. Neely AN, Maley MP. Survival of enterococci and staphylococci on hospital fabrics and plastic. J. Clin. Microbiol. 2000;38:724-6.
  396. Wendt C, Wiensenthal B, Dietz E, Ruden H. Survival of enterococci on dry surfaces. J. Clin. Microbiol. 1998;36:3734-6.
  397. Neely AN, Maley MP. The 1999 Lindberg award. 3% hydrogen peroxide for the gram-positive disinfection of fabrics. J. Burn Care Rehabil. 1999;20:471-7.
  398. Griffith CJ, Cooper RA, Gilmore J, Davies C, Lewis M. An evaluation of hospital cleaning regimes and standards. J. Hosp. Infect. 2000;45:19-28.
  399. Tiller JC, Liao CJ, Lewis K, Klibanov AM. Designing surfaces that kill bacteria on contact. Proc. Natl. Acad. Sci. 2001;98:5981-5.
  400. Rutala WA, Weber DJ. New disinfection and sterilization methods. Emerg. Inf. Dis. 2001;7:348-53.
  401. Whitby JL, Rampling A. Pseudomonas aeruginosa contamination in domestic and hospital environments. Lancet 1972;1:15-7.
  402. Scott E, Bloomfield SF. The survival and transfer of microbial contamination via cloths, hand and utensils. J. Appl. Bacteriol. 1990;68:271-8.
  403. Scott E, Bloomfield SF. Investigations of the effectiveness of detergent washing, drying and chemical disinfection on contamination of cleaning cloths. J. Appl. Bacteriol. 1990;68:279-83.
  404. Rutala WA, Cole EC. Antiseptics and disinfectants--safe and effective? Infect. Control 1984;5:215-8.
  405. Oie S, Huang Y, Kamiya A, Konishi H, Nakazawa T. Efficacy of disinfectants against biofilm cells of methicillin-resistant Staphylococcus aureus. Microbios 1996;85:223-30.
  406. Sartor C, Jacomo V, Duvivier C, Tissot-Dupont H, Sambuc R, Drancourt M. Nosocomial Serratia marcescens infections associated with extrinsic contamination of a liquid nonmedicated soap. Infect. Control Hosp. Epidemiol. 2000;21:196-9.
  407. Reiss I, Borkhardt A, Fussle R, Sziegoleit A, Gortner L. Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies. Lancet 2000;356:310.
  408. O'Rourke E, Runyan D, O'Leary J, Stern J. Contaminated iodophor in the operating room. Am. J. Infect. Control 2003;31:255-6.
  409. Chuanchuen R, Karkhoff-Schweizer RR, Schweizer HP. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am. J. Infect. Control 2003;31:124-7.
  410. Newman KA, Tenney JH, Oken HA, Moody MR, Wharton R, Schimpff SC. Persistent isolation of an unusual Pseudomonas species from a phenolic disinfectant system. Infect. Control 1984;5:219-22.
  411. Bean HS. Types and characteristics of disinfectants. J. Appl. Bacteriol. 1967;30:6-16.
  412. Russell AD, Hugo WB, Ayliffe GAJ. Principles and Practice of Disinfection, Preservation and Sterilization. Oxford, England: Blackwell Scientific Publications, 1999.
  413. Russell AD. Factors influencing the efficacy of germicides. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington DC: Association for Professionals in Infection Control and Epidemiology, 2004:162-70.
  414. Gillis RJ, Schmidt WC. Scanning electron microscopy of spores on inoculated product surfaces. MD 1983:46-9.
  415. Favero MS, Petersen NJ, Carson LA, Bond WW, Hindman SH. Gram-negative water bacteria in hemodialysis systems. Health Lab. Sci. 1975;12:321-34.
  416. Rutala WA, Cole EC. Ineffectiveness of hospital disinfectants against bacteria: a collaborative study. Infect. Control 1987;8:501-6.
  417. Favero MS. Naturally occurring microrganisms and their resistance to physical and chemical agents. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington DC: Association for Professionals in Infection Control and Epidemiology, 2004:1-14.
  418. Lee DH, Miles RJ, Perry BF. The mycoplasmacidal properties of sodium hypochlorite. J. Hyg. (Lond). 1985;95:243-53.
  419. Scott GH, Williams JC. Susceptibility of Coxiella burnetii to chemical disinfectants. Ann. N. Y. Acad. Sci. 1990;590:291-6.
  420. Russell AD. Factors influencing the efficacy of antimicrobial agents. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and practice of disinfection, preservation and sterilization. Oxford: Blackwell Science, 1999:95-123.
  421. Rutala WA. Selection and use of disinfectants in healthcare. In: Mayhall CG, ed. Infect. Control and Hosp. Epidemiol. Philadelphia: Lippincott Williams & Wilkins, 1999:1161-87.
  422. Lewis DL, Arens M. Resistance of microorganisms to disinfection in dental and medical devices. Nat. Med. 1995;1:956-8.
  423. Muscarella LF. Sterilizing dental equipment. Nat. Med. 1995;1:1223-5.
  424. Abbott CF, Cockton J, Jones W. Resistance of crystalline substances to gas sterilization. J. Pharm. Pharmacol. 1956;8:709-20.
  425. Doyle JE, Ernst RR. Resistance of Bacillus subtilis var. niger spores occluded in water-insoluble crystals to three sterilization agents. Appl. Microbiol. 1967;15:726-30.
  426. Jacobs P. Cleaning: Principles, methods and benefits. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:165-81.
  427. Gorham RA, Jacobs P, Roberts CG. Laboratory artifacts due to protein and salt crystals on the inactivation of Bacillus stearothermophilus. J. Hosp. Infect. 1998;40:abstract P.9.2.2.
  428. Cole EC, Rutala WA, Carson JL, Alfano EM. Pseudomonas pellicle in disinfectant testing: electron microscopy, pellicle removal, and effect on test results. Appl. Environ. Microbiol. 1989;55:511-3.
  429. Anderson RL, Holland BW, Carr JK, Bond WW, Favero MS. Effect of disinfectants on pseudomonads colonized on the interior surface of PVC pipes. Am. J. Public Health 1990;80:17-21.
  430. Anderson RL, Vess RW, Carr JH, Bond WW, Panlilio AL, Favero MS. Investigations of intrinsic Pseudomonas cepacia contamination in commercially manufactured povidone-iodine. Infect. Control Hosp. Epidemiol. 1991;12:297-302.
  431. LeChevallier MW, Cawthon CD, Lee RG. Inactivation of biofilm bacteria. Appl. Environ. Microbiol. 1988;54:2492-9.
  432. LeChevallier MW, Cawthon CD, Lee RG. Factors promoting survival of bacteria in chlorinated water supplies. Appl. Environ. Microbiol. 1988;54:649-54.
  433. Costerton JS, Steward PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999;284:1318-22.
  434. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant mirocorganisms. Clin. Microbiol. Rev. 2002;15:167-93.
  435. Dunne WM. Bacterial adhesion: Seen any good biofilms lately? Clin. Microbiol. Rev. 2002;15:155-66.
  436. Vickery K, Pajkos A, Cossart Y. Removal of biofilm from endoscopes: Evaluation of detergent efficiency. Am. J. Infect. Control 2004;32:170-6.
  437. Marion K, Freney J, James G, Bergeron E, Renaud FNR, Costerton JW. Using an efficient biofilm detaching agent: An essential step for the improvement of endoscope reprocessing protocols. J. Hosp. Infect. 2006;In press.
  438. Marion-Ferey K, Pasmore M, Stoodley P, Wilson S, Husson GP, Costerton JW. Biofilm removal from silicone tubing: an assessment of the efficacy of dialysis machine decontamination procedures using an in vitro model. J. Hosp. Infect. 2003;53:64-71.
  439. Brown ML, Aldrich HC, Gauthier JJ. Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. Appl. Environ. Microbiol. 1995;61:187-93.
  440. Price D, Ahearn DG. Incidence and persistence of Pseudomonas aeruginosa in whirlpools. J. Clin. Microbiol. 1988;26:1650-4.
  441. Anonymous. Dental Unit Waterlines: Approaching the Year 2000. ADA Council on Scientific Affairs. JADA 1999;130:1653-64.
  442. Donlan RM. Biofilms: a source of infection? In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:219-26.
  443. Loukili NH, Zink E, Grandadam S, Bientz M, Meunier O. Effectiveness of detergent-disinfecting agents on Escherichia coli 54127 biofilm. J. Hosp. Infect. 2004;57:175-8.
  444. Johansen C, Falholt P, Gram L. Enzymatic removal and disinfection of bacterial biofilms. Appl. Environ. Microbiol. 1997;63:3724-8.
  445. Reichert M. Preparation of supplies for terminal sterilization. In: Reichert M, Young JH, eds. Sterilization technology for the health care facility. Gaithersburg, MD: Aspen Publication, 1997:36-50.
  446. Miller CH, Riggen SD, Sheldrake MA, Neeb JM. Presence of microorganisms in used ultrasonic cleaning solutions. Am. J. Dent. 1993;6:27-31.
  447. Jatzwauk L, Schone H, Pietsch H. How to improve instrument disinfection by ultrasound. J. Hosp. Infect. 2001;48 (Supple):S80-S83.
  448. Richburg FA, Reidy JJ, Apple DJ, Olson RJ. Sterile hypopyon secondary to ultrasonic cleaning solution. J. Cataract Refract. Surg. 1986;12:248-51.
  449. Schultz JK. Decontamination alternative. Infect. Control Hosp. Epidemiol. 1990;11:8-9.
  450. Rutala WA, Shafer KM. General information on cleaning, disinfection, and sterilization. In: Pfeiffer JA, ed. APIC infection control and applied epidemiology: principles and practice,. St. Louis: Mosby, 1996:15.1-15.17.
  451. Leonard DL, Mills SE. Comparison of automated instrument cleaning: preliminary results. Infect. Control Steril. Technol. 1997:20-23, 26-28.
  452. Ransjo U, Engstrom L, Hakansson P, et al. A test for cleaning and disinfection processes in a washer-disinfector. APMIS 2001;109:299-304.
  453. American Society for Hospital Central Service Personnel. Training manual for central service technicians. Chicago: American Hospital Association, 2001:1-271.
  454. Ninemeier JD. Central service technical manual. Chicago: International Association of Healthcare Central Service Materiel Management, 1998.
  455. Reichert M, Young JH. Sterilization technology for the health care facility. Gaithersburg: Aspen Publication, 1997:307.
  456. Vesley D, Norlien KG, Nelson B, Ott B, Streifel AJ. Significant factors in the disinfection and sterilization of flexible endoscopes. Am. J. Infect. Control 1992;20:291-300.
  457. Roberts CG. Studies on the bioburden on medical devices and the importance of cleaning. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:63-9.
  458. Baxter RL, Baxter HC, Campbell GA, et al. Quantitaive analysis of residual protein contamination on reprocessed surgical instruments. J. Hosp. Infect. 2006;63:439-44.
  459. Murdoch H, Taylor D, Dickinson J, et al. Surface decontamination of surgical instruments: An ongoing dilemma. J. Hosp. Infect. 2006;63:432-8.
  460. Alfa MJ, Nemes R. Manual versus automated methods for cleaning reusable accessory devices used for minimally invasine surgical procedures. J. Hosp. Infect. 2004;58:50-8.
  461. Alfa MJ, Nemes R, Olson N, Mulaire A. Manual methods are suboptimal compared with automated methods for cleaning of single-use biopsy forceps. Infect Control Hosp Epidemiol 2006;27:841-6.
  462. Lee CH, Cheng SM, Humar A, et al. Acute febrile reactions with hypotension temporally associated with the introduction of a concentrated bioenzyme preparation in the cleaning and sterilization process of endomyocardial bioptones. Infect. Control Hosp. Epidemiol. 2000;21:102.
  463. Hutchisson B, LeBlanc C. The truth and consequences of enzymatic detergents. Gastroenterol. Nurs. 2005;28:372-6.
  464. Zuhlsdorf B EM, Floss H, Martiny H,. Cleaning efficacy of nine different cleaners in a washer-disinfector designed for flexible endoscopes. J. Hosp. Infect. 2002;52:206-11.
  465. Merritt K, Hitchins VM, Brown SA. Safety and cleaning of medical materials and devices. J. Biomed. Mater. Res. 2000;53:131-6.
  466. Babb JR, Bradley CR. Endoscope decontamination: where do we go from here? J. Hosp. Infect. 1995;30:543-51.
  467. Zuhlsdorf B, Floss H, Martiny H. Efficacy of 10 different cleaning processes in a washer-disinfector for flexible endoscopes. J. Hosp. Infect. 2004;56:305-11.
  468. Alfa MJ, Jackson M. A new hydrogen peroxide-based medical-device detergent with germicidal properties: Comparison with enzymatic cleaners. Am. J. Infect. Control 2001;29:168-77.
  469. Alfa MJ, DeGagne P, Olson N, Puchalski T. Comparison of ion plasma, vaporized hydrogen peroxide and 100% ethylene oxide sterilizers to the 12/88 ethylene oxide gas sterilizer. Infect. Control Hosp. Epidemiol. 1996;17:92-100.
  470. Alfa MJ. Flexible endoscope reprocessing. Infect. Control Steril. Technol. 1997;3:26-36.
  471. Alfa MJ, Degagne P, Olson N. Worst-case soiling levels for patient-used flexible endoscopes before and after cleaning. Am. J. Infect. Control 1999;27:392-401.
  472. Rutala WA, Weber DJ. Low-temperature sterilization technology: Do we need to redefine sterilization? Infect. Control Hosp. Epidemiol. 1996;17:89-91.
  473. Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J. Hosp. Infect. 2004;56:10-5.
  474. Pfeifer M. Standardised test soil blood 1:Composition, preparation, application. Zentr. Steril. 1998;6:381-5.
  475. Pfeifer M. Blood as a soil on surgical instruments: Chemical profile, cleaning, detection. Zentr. Steril. 1998;6:304-10.
  476. Fengier TW, Pahike H, Bisson S, Michels W. Are processed surgical instruments free of protein? Zentr. Steril. 2001;9:20-32.
  477. Takashina M. Application of a bioluminescent method for checking cleaning results. Zentr. Steril. 2001;9:248-58.
  478. Lipscomb IP, Sihota AK, Botham M, Harris KL, Keevil CW. Rapid method for the sensitive detection of protein contamination on surgical instruments. J. Hosp. Infect. 2006;62:141-8.
  479. Malik RE, Cooper RA, Griffith CJ. Use of audit tools to evaluate the efficacy of cleaning systems in hospitals. Am. J. Infect. Control 2003;31:181-7.
  480. Hansen KS. Occupational dermatoses in hospital cleaning women. Contact Dermatitis 1983;9:343-51.
  481. Melli MC, Giorgini S, Sertoli A. Sensitization from contact with ethyl alcohol. Contact Dermatitis 1986;14:315.
  482. Spaulding EH. Alcohol as a surgical disinfectant. AORN J. 1964;2:67-71.
  483. Morton HE. The relationship of concentration and germicidal efficiency of ethyl alcohol. Ann N.Y. Acad. Sci. 1950;53:191-96.
  484. Ali Y, Dolan MJ, Fendler EJ, Larson EL. Alcohols. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:229-54.
  485. Morton HE. Alcohols. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1983:225-239.
  486. Sykes G. The influence of germicides on the dehydrogenases of Bact. coli. Part I. The succinic acid dehydrogenase of Bact. coli. J. Hyg. (Camb) 1939;39:463-69.
  487. Dagley S, Dawes EA, Morrison GA. Inhibition of growth of Aerobacter aerogenes: the mode of action of phenols, alcohols, acetone and ethyl acetate. J. Bacteriol. 1950;60:369-78.
  488. Tilley FW, Schaffer JM. Relation between the chemical constitution and germicidal activity of the monohydric alcohols and phenols. J. Bacteriol. 1926;12:303-9.
  489. Coulthard CE, Sykes G. The germicidal effect of alcohol with special reference to its action on bacterial spores. Pharmaceutical J. 1936;137:79-81.
  490. Tyler R, Ayliffe GA. A surface test for virucidal activity of disinfectants: preliminary study with herpes virus. J. Hosp. Infect. 1987;9:22-9.
  491. Kurtz JB, Lee TW, Parsons AJ. The action of alcohols on rotavirus, astrovirus and enterovirus. J. Hosp. Infect. 1980;1:321-5.
  492. Smith CR. Alcohol as a disinfectant against the tubercle bacillus. Public Health Rep. 1947;62:1285-95.
  493. Kruse RH, Green TD, Chambers RC, Jones MW. Disinfection of aerosolized pathogenic fungi on laboratory surfaces. 1. Tissue phase. Appl. Microbiol. 1963;11:436-45.
  494. Kruse RH, Green TD, Chambers RC, Jones MW. Disinfection of aerosolized pathogenic fungi on laboratory surfaces. II Culture phase. Appl. Microbiol. 1964;12:155-60.
  495. Connor CG, Hopkins SL, Salisbury RD. Effectivity of contact lens disinfection systems against Acanthamoeba culbertsoni. Optom. Vis. Sci. 1991;68:138-41.
  496. Turner NA, Russell AD, Furr JR, Lloyd D. Acanthamoeba spp., antimicrobial agents and contact lenses. Sci. Prog. 1999;82:1-8.
  497. Nye RN, Mallory TB. A note on the fallacy of using alcohol for the sterilization of surgical instruments. Boston Med. Surg. J. 1923;189:561-3.
  498. Frobisher M, Sommermeyer L, Blackwell MJ. Studies on disinfection of clinical thermometers. I. Oral thermometers. Appl. Microbiol. 1973;1:187-94.
  499. Sommermeyer L, Frobisher M. Laboratory studies on disinfection of rectal thermometers. Nurs. Res. 1973;2:85-9.
  500. Singh D, Kaur H, Gardner WG, Treen LB. Bacterial contamination of hospital pagers. Infect . Control Hosp. Epidemiol. 2002;23:274-6.
  501. Embil JM, Zhanel GG, Plourde J, Hoban D. Scissors: A potential source of nosocomial infection. Infect . Control Hosp. Epidemiol. 2002;23:147-51.
  502. Zachary KC, Bayne PS, Morrison VJ, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect . Control Hosp. Epidemiol. 2001;22:560-4.
  503. Babb JR, Bradley CR, Deverill CE, Ayliffe GA, Melikian V. Recent advances in the cleaning and disinfection of fibrescopes. J. Hosp. Infect. 1981;2:329-40.
  504. Garcia de Cabo A, Martinez Larriba PL, Checa Pinilla J, Guerra Sanz F. A new method of disinfection of the flexible fibrebronchoscope. Thorax 1978;33:270-2.
  505. Elson CO, Hattori K, Blackstone MO. Polymicrobial sepsis following endoscopic retrograde cholangiopancreatography. Gastroenterology 1975;69:507-10.
  506. Weber DJ, Wilson MB, Rutala WA, Thomann CA. Manual ventilation bags as a source for bacterial colonization of intubated patients. Am. Rev. Respir. Dis. 1990;142:892-4.
  507. Cavagnolo RZ. Inactivation of herpesvirus on CPR manikins utilizing a currently recommended disinfecting procedure. Infect. Control 1985;6:456-8.
  508. Ohara T, Itoh Y, Itoh K. Ultrasound instruments as possible vectors of staphylococcal infection. J. Hosp. Infect. 1998;40:73-7.
  509. Talbot GH, Skros M, Provencher M. 70% alcohol disinfection of transducer heads: experimental trials. Infect. Control 1985;6:237-9.
  510. Platt R, Lehr JL, Marino S, Munoz A, Nash B, Raemer DB. Safe and cost-effective cleaning of pressure-monitoring transducers. Infect. Control Hosp. Epidemiol. 1988;9:409-16.
  511. Beck-Sague CM, Jarvis WR. Epidemic bloodstream infections associated with pressure transducers: a persistent problem. Infect. Control Hosp. Epidemiol. 1989;10:54-9.
  512. Chronister CL, Russo P. Effects of disinfecting solutions on tonometer tips. Optom. Vis. Sci. 1990;67:818-21.
  513. Lingel NJ, Coffey B. Effects of disinfecting solutions recommended by the Centers for Disease Control on Goldmann tonometer biprisms. J. Am. Optom. Assoc. 1992;63:43-8.
  514. Soukiasian SH, Asdourian GK, Weiss JS, Kachadoorian HA. A complication from alcohol-swabbed tonometer tips. Am. J. Ophthalmol. 1988;105:424-5.
  515. Jakobsson SW, Rajs J, Jonsson JA, Persson H. Poisoning with sodium hypochlorite solution. Report of a fatal case, supplemented with an experimental and clinico-epidemiological study. Am. J. Forensic Med. Pathol. 1991;12:320-7.
  516. Heidemann SM, Goetting MG. Treatment of acute hypoxemic respiratory failure caused by chlorine exposure. Pediatr. Emerg. Care 1991;7:87-8.
  517. Hoy RH. Accidental systemic exposure to sodium hypochlorite (Clorox) during hemodialysis. Am. J. Hosp. Pharm. 1981;38:1512-4.
  518. Landau GD, Saunders WH. The effect of chlorine bleach on the esophagus. Arch. Otolaryngol. 1964;80:174-6.
  519. French RJ, Tabb HG, Rutledge LJ. Esophageal stenosis produced by ingestion of bleach: report of two cases. South. Med. J. 1970;63:1140-4.
  520. Ward MJ, Routledge PA. Hypernatraemia and hyperchloraemic acidosis after bleach ingestion. Hum. Toxicol. 1988;7:37-8.
  521. Ingram TA. Response of the human eye to accidental exposure to sodium hypochlorite. J Endodontics 1990;16:235-8.
  522. Haag JR, Gieser RG. Effects of swimming pool water on the cornea. JAMA 1983;249:2507-8.
  523. Mrvos R, Dean BS, Krenzelok EP. Home exposures to chlorine/chloramine gas: review of 216 cases. South. Med. J. 1993;86:654-7.
  524. Reisz GR, Gammon RS. Toxic pneumonitis from mixing household cleaners. Chest 1986;89:49-52.
  525. Gapany-Gapanavicius M, Yellin A, Almog S, Tirosh M. Pneumomediastinum. A complication of chlorine exposure from mixing household cleaning agents. JAMA 1982;248:349-50.
  526. Hoffman PN, Death JE, Coates D. The stability of sodium hypochlorite solutions. In: Collins CH, Allwood MC, Bloomfield SF, Fox A, eds. Disinfectants: their use and evaluation of effectiveness. London: Academic Press, 1981:77-83.
  527. Gamble MR. Hazard: formaldehyde and hypochlorites. Lab. Anim. 1977;11:61.
  528. Helms C, Massanari R, Wenzel R, et al. Control of epidemic nosocomial legionellosis: a 5 year progress report on continuous hyperchlorination of a water distribution system. Abstracts of 27th Interscience Conference of Antimicrobial Agents and Chemotherapy, 1987:349, p.158.
  529. Environmental Protection Agency. R.E.D. Facts sodium and calcium hypochlorite salts. 1991.
  530. Coates D. Comparison of sodium hypochlorite and sodium dichloroisocyanurate disinfectants: neutralization by serum. J. Hosp. Infect. 1988;11:60-7.
  531. Coates D. A comparison of sodium hypochlorite and sodium dichloroisocyanurate products. J. Hosp. Infect. 1985;6:31-40.
  532. Coates D, Wilson M. Use of sodium dichloroisocyanurate granules for spills of body fluids. J. Hosp. Infect. 1989;13:241-51.
  533. Bloomfield SF, Uso EE. The antibacterial properties of sodium hypochlorite and sodium dichloroisocyanurate as hospital disinfectants. J. Hosp. Infect. 1985;6:20-30.
  534. Coates D. An evaluation of the use of chlorine dioxide (Tristel One-Shot) in an automated washer/disinfector (Medivator) fitted with a chlorine dioxide generator for decontamination of flexible endoscopes. J. Hosp. Infect. 2001;48:55-65.
  535. Isomoto H, Urata M, Kawazoe K, et al. Endoscope disinfection using chlorine dioxide in an automated washer-disinfector. J. Hosp. Infect. 2006;63:298-305.
  536. Sampson MN MA. Not all super-oxidized waters are the same. J. Hosp. Infect. 2002;52:227-8.
  537. Selkon JB, Babb JR, Morris R. Evaluation of the antimicrobial activity of a new super-oxidized water, Sterilox®, for the disinfection of endoscopes. J. Hosp. Infect. 1999;41:59-70.
  538. Fraise AP. Choosing disinfectants. J. Hosp. Infect. 1999;43:255-64.
  539. Tanaka H, Hirakata Y, Kaku M, et al. Antimicrobial activity of superoxidized water. J. Hosp. Infect. 1996;34:43-9.
  540. Tanaka N, Fujisawa T, Daimon T, Fujiwara K, Yamamoto M, Abe T. The use of electrolyzed solutions for the cleaning and disinfecting of dialyzers. Artif. Organs 2000;24:921-8.
  541. Williams ND, Russell AD. The effects of some halogen-containing compounds on Bacillus subtilis endospores. J. Appl. Bacteriol. 1991;70:427-36.
  542. Babb JR, Bradley CR, Ayliffe GAJ. Sporicidal activity of glutaraldehydes and hypochlorites and other factors influencing their selection for the treatment of medical equipment. J. Hosp. Infect. 1980;1:63-75.
  543. Brown DG, Skylis TP, Fekety FR. Comparison of chemical sterilant/disinfectant solutions against spores of Clostridium difficile. Abstracts of the American Society for Microbiology, 1983:Q39,267.
  544. Grant D, Venneman M, Burns RM. Mycobactericidal activity of Alcide an experimental liquid sterilant. Abstracts of the Annual Meeting of the American Society of Microbiology, 1982: Q101,226.
  545. Korich DG, Mead JR, Madore MS, Sinclair NA, Sterling CR. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability. Appl. Environ. Microbiol. 1990;56:1423-8.
  546. Griffiths PA, Babb JR, Fraise AP. Mycobactericidal activity of selected disinfectants using a quantitative suspension test. J. Hosp. Infect. 1999;41:111-21.
  547. Centers for Disease Control. Bacteremia associated with reuse of disposable hollow-fiber hemodialyzers. MMWR 1986;35:417-8.
  548. Bloomfield SF, Miller EA. A comparison of hypochlorite and phenolic disinfectants for disinfection of clean and soiled surfaces and blood spillages. J. Hosp. Infect. 1989;13:231-9.
  549. Shetty N, Srinivasan S, Holton J, Ridgway GL. Evaluation of microbicidal activity of a new disinfectant: Sterilox® 2500 against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicans and several Mycobacterium species. J. Hosp. Infect. 1999;41:101-5.
  550. Urata M, Isomot H, Murase K, et al. Comparison of the microbicidal activities of superoxidized and ozonated water in the disinfection of endoscopes. J Intern Med Res 2003;31:299-306.
  551. Tsuji S, Kawano S, Oshita M, et al. Endoscope disinfection using acidic electrolytic water. Endoscopy 1999;31:528-35.
  552. Lee JH, Rhee PL, Kim JH, et al. Efficacy of electolyzed acid water in reprocessing patient-used flexible upper endoscopes: Comparison with 2% alkaline glutaraldehyde. J. Gastroenterol. Hepatol. 2004;19:897-904.
  553. Centers for Disease Control. Acquired immune deficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR 1982;31:577-80.
  554. Garner JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect. Control 1983;4:245-325.
  555. Van Bueren J, Simpson RA, Salman H, Farrelly HD, Cookson BD. Inactivation of HIV-1 by chemical disinfectants: sodium hypochlorite. Epidemiol. Infect. 1995;115:567-79.
  556. Coates D. Disinfection of spills of body fluids: how effective is a level of 10,000 ppm available chlorine? J. Hosp. Infect. 1991;18:319-22.
  557. Chitnis V, Chitnis S, Patil S, Chitnis D. Practical limitations of disinfection of body fluid spills with 10,000 ppm sodium hypochlorite (NaOCl). Am. J. Infect. Control 2004;32:306-8.
  558. Anonymous. Recommendations for decontaminating manikins used in cardiopulmonary resuscitation training, 1983 update. Infect . Control 1984;5:399-401.
  559. Centers for Disease Control. Use of bleach for disinfection of drug injection equipment. MMWR 1993;42:418-9.
  560. Shapshak P, McCoy CB, Rivers JE, et al. Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. J. Acquir. Immune Defic. Syndr. 1993;6:218-9.
  561. Shapshak P, McCoy CB, Shah SM, et al. Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach. J. Acquir. Immune Defic. Syndr. 1994;7:754-9.
  562. Brystrom A, Sundqvist G. Bacteriologic evaluation of the effect of 0.5 percent sodium hypochlorite in endodontic therapy. Oral Surg. Oral Med. Oral Pathol. 1983;55:307-12.
  563. Favero MJ, Tokars JI, Arduino MJ, Alter MJ. Nosocomial infections associated with hemodialysis. In: Mayhall CG, ed. Infect. Control and Hosp. Epidemiol. Philadelphia: Lippincott Williams & Wilkins, 1999:897-917.
  564. Helms CM, Massanari RM, Zeitler R, et al. Legionnaires' disease associated with a hospital water system: a cluster of 24 nosocomial cases. Ann. Intern. Med. 1983;99:172-8.
  565. Heffelfinger JD, Kool JL, Fridkin S, et al. Risk of hospital-acquired legionnaires' disease in cities using monchloramine versus other water disinfectants. Infect Control Hosp Epidemiol 2003;24:569-74.
  566. Moore MR, Pryor M, Fields B, Lucas C, Phelan M, Besser RE. Introduction of monochloramine into a municipal water system: Impact on colonization of buildings by Legionella spp. Appl. Environ. Microbiol. 2006;72:378-83.
  567. Srinivasan A, Bova G, Ross T, et al. A 17-month evaluation of a chlorine dioxide water treatment system to control Legionella species in a hospital water supply. Infect Control Hosp Epidemiol 2003;24:575-9.
  568. Steve L, Goodhart P, Alexander J. Hydrotherapy burn treatment: use of chloramine-T against resistant microorganisms. Arch. Phys. Med. Rehabilit. 1979;60:301-3.
  569. Coates D, Wilson M. Powders, composed of chlorine-releasing agent acrylic resin mixtures or based on peroxygen compounds, for spills of body fluids. J. Hosp. Infect. 1992;21:241-52.
  570. Tulis JJ. Formaldehyde as a gas. In: Phillips GB, Miller WS, eds. Industrial Sterilization. Durham: Duke University Press, 1972:209-38.
  571. Emmons CW. Fungicidal action of some common dsinfectants on two dermatophytes. Arch. Dermatol. Syphil. 1933;28:15-21.
  572. McCulloch EC, Costigan S. A comparison of the efficiency of phenol, liquor cresolis, formaldehyde, sodium hypochlorite and sodium hydroxide against Eberthella typhi at various temperatures. J. Infect. Dis. 1936;59:281-4.
  573. Sagripanti JL, Eklund CA, Trost PA, et al. Comparative sensitivity of 13 species of pathogenic bacteria to seven chemical germicides. Am. J. Infect. Control 1997;25:335-9.
  574. NIOSH. Formaldehyde: evidence of carcinogenicity. NIOSH Current Intelligence Bulletin 34. DHEW (NIOSH) Publication No. 81-111. 1981.
  575. Occupational Safety and Health Administration. OSHA amends formaldehyde standard. Occupational Safety and Health News 1991:1.
  576. Occupational Health and Safety Administration. OSHA Fact Sheet: Formaldehyde: Occupational Safety and Health Administration, U.S. Department of Labor, 2002.
  577. Occupational Safety and Health Administration. Air Contaminants Final Rule. Fed. Regist. 1993;58:35338-51.
  578. Occupational Safety and Health Administration. Formaldehyde: OSHA Fact Sheet: Occupational Safety and Health Administration, 2002.
  579. Centers for Disease Control. Occupational exposures to formaldehyde in dialysis units. MMWR 1986;35:399-01.
  580. Centers for Disease Control. Formaldehyde exposures in a gross anatomy laboratory - Colorado. MMWR 1983;52:698-700.
  581. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis associated diseases in the United States, 1995. ASAIO J. 1998;44:98-107.
  582. Favero MS, Alter MJ, Tokars JI, Bland LA. Dialysis-associated disease and their control. In: Bennett JV, Brachman PS, eds. Hospital Infections. Boston: Little, Brown and Company, 1998:357-80.
  583. Bland LA, Favero MS. Microbial contamination control strategies for hemodialysis system. Plant, Technology & Safety Management Series: infection control issues in PTSM 1990. Oakbrook Terrace, Illinois.
  584. Boucher RM. Potentiated acid 1,5 pentanedial solution--a new chemical sterilizing and disinfecting agent. Am. J. Hosp. Pharm. 1974;31:546-57.
  585. Miner NA, McDowell JW, Willcockson GW, Bruckner NI, Stark RL, Whitmore EJ. Antimicrobial and other properties of a new stabilized alkaline glutaraldehyde disinfectant/sterilizer. Am. J. Hosp. Pharm. 1977;34:376-82.
  586. Pepper RE. Comparison of the activities and stabilities of alkaline glutaraldehyde sterilizing solutions. Infect. Control 1980;1:90-2.
  587. Leach ED. A new synergized glutaraldehyde-phenate sterilizing solution and concentrated disinfectant. Infect. Control 1981;2:26-30.
  588. Miner NA, Ross C. Clinical evaluation of ColdSpor, a glutaraldehyde-phenolic disinfectant. Respir. Care 1991;36:104-9.
  589. Collins FM, Montalbine V. Mycobactericidal activity of glutaraldehyde solutions. J. Clin. Microbiol. 1976;4:408-12.
  590. Masferrer R, Marquez R. Comparison of two activated glutaraldehyde solutions: Cidex Solution and Sonacide. Respir. Care 1977;22:257-62.
  591. Jette LP, Ringuette L, Ishak M, Miller M, Saint-Antoine P. Evaluation of three glutaraldehyde-based disinfectants used in endoscopy. J. Hosp. Infect. 1995;30:295-303.
  592. Scott EM, Gorman SP. Glutaraldehyde. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:361-81.
  593. Scott EM, Gorman SP. Glutaraldehyde. In: Block SS, ed. Disinfection, Sterilization, and Preservation. Philadelphia: Lea & Febiger, 1991:596-616.
  594. Stonehill AA, Krop S, Borick PM. Buffered glutaraldehyde - a new chemical sterilizing solution. Am. J. Hosp. Pharm. 1963;20:458-65.
  595. Borick PM, Dondershine FH, Chandler VL. Alkalinized glutaraldehyde, a new antimicrobial agent. J. Pharm. Sci. 1964;53:1273-5.
  596. Russell AD. Glutaraldehyde: current status and uses. Infect. Control Hosp. Epidemiol. 1994;15:724-33.
  597. Hanson PJ, Bennett J, Jeffries DJ, Collins JV. Enteroviruses, endoscopy and infection control: an applied study. J. Hosp. Infect. 1994;27:61-7.
  598. van Klingeren B, Pullen W. Glutaraldehyde resistant mycobacteria from endoscope washers. J. Hosp. Infect. 1993;25:147-9.
  599. Griffiths PA, Babb JR, Bradley CR, Fraise AP. Glutaraldehyde-resistant Mycobacterium chelonae from endoscope washer disinfectors. J. Appl. Microbiol. 1997;82:519-26.
  600. Dauendorffer JN, Laurain C, Weber M, Dailloux M. Evaluation of the bactericidal efficiency of a 2% alkaline glutaraldehyde solution on Mycobacterium xenopi. J. Hosp. Infect. 2000;46:73-6.
  601. Nomura K, Ogawa M, Miyamoto H, Muratani T, Taniguchi H. Antibiotic susceptibility of glutaraldehyde-tolerant Mycobacterium chelonae from bronchoscope washing machines. J. Hosp. Infect. 2004;32:185-8.
  602. Webster E, Ribner B, Streed LL, Hutton N. Microbial contamination of activated 2% glutaraldehyde used in high-level disinfection of endoscopes (abstract). Am. J. Infect. Control 1996;24:153.
  603. Casemore DP, Blewett DA, Wright SE. Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a Working Party of the British Society of Gastroenterology. Gut 1989;30:1156-7.
  604. Laskowski LF, Marr JJ, Spernoga JF, et al. Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures. N. Engl. J. Med. 1977;297:101-2.
  605. Collins FM. Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species. J. Appl. Bacteriol. 1986;61:247-51.
  606. Food and Drug Administration. Sterilants and high level disinfectants cleared by FDA in a 510(k) as of January 30, 2002 with general claims for processing reusable medical and dental devices, htpp://www.fda.gov/cdrh/ode/germlab.html., 2001.
  607. Hernandez A, Martro E, Pizo C, et al. In-use evaluation of Perasafe compared with Cidex in fibreoptic bronchoscope disinfection. J. Hosp. Infect. 2003;54:46-52.
  608. Leong D, Dorsey G, Klapp M. Dilution of glutaraldehyde by automatic endoscope machine washers: the need for a quality control program. Abstracts of the 14th Annual Educational Conference of Association for Practitioners in Infection Control, 1987:108, p.130.
  609. Mbithi JN, Springthorpe VS, Sattar SA, Pacquette M. Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit. J. Clin. Microbiol. 1993;31:2988-95.
  610. Kleier DJ, Averbach RE. Glutaraldehyde nonbiologic monitors. Infect. Control Hosp. Epidemiol. 1990;11:439-41.
  611. Kleier DJ, Tucker JE, Averbach RE. Clinical evaluation of glutaraldehyde nonbiologic monitors. Quintessence Int. 1989;20:271-7.
  612. Overton D, Burgess JO, Beck B, Matis B. Glutaraldehyde test kits: evaluation for accuracy and range. Gen. Dent. 1989;37:126, 128.
  613. Cooke RPD, Goddard SV, Chatterley R, Whymant-Morris A, Cheale J. Monitoring glutaraldehyde dilution in automated washer/disinfectors. J. Hosp. Infect. 2001;48:242-6.
  614. Ayliffe GA, Babb JR, Bradley CR. Disinfection of endoscopes. J. Hosp. Infect. 1986;7:296-9.
  615. Centers for Disease Control. Federal regulatory action against sporicidin cold sterilizing solution. MMWR 1991;40:880-1.
  616. Husni L, Kale E, Climer C, Bostwick B, Parker TF, 3rd. Evaluation of a new disinfectant for dialyzer reuse. Am. J. Kidney Dis. 1989;14:110-8.
  617. Townsend TR, Wee SB, Koblin B. An efficacy evaluation of a synergized glutaraldehyde-phenate solution in disinfecting respiratory therapy equipment contaminated during patient use. Infect. Control 1982;3:240-4.
  618. Petersen NJ, Carson LA, Doto IL, Aguero SM, Favero MS. Microbiologic evaluation of a new glutaraldehyde-based disinfectant for hemodialysis systems. Trans. Am. Soc. Artif. Intern. Organs 1982;28:287-90.
  619. Gundogdu H, Ocal K, Caglikulekci M, Karabiber N, Bayramoglu E, Karahan M. High-level disinfection with 2% alkalinized glutaraldehyde solution for reuse of laparoscopic disposable plastic trocars. J. Laparoendosc. Adv. Surg. Techniques. Part A 1998;8:47-52.
  620. Castelli M, Qizilbash A, Seaton T. Post-colonoscopy proctitis. Am. J. Gastroenterol. 1986;81:887.
  621. Jonas G, Mahoney A, Murray J, Gertler S. Chemical colitis due to endoscope cleaning solutions: a mimic of pseudomembranous colitis. Gastroenterology 1988;95:1403-8.
  622. Levine DS. Proctitis following colonoscopy. Gastrointest. Endosc. 1988;34:269-72.
  623. Riney S, Grimes M, Khalife K, Warbasse L, Massanari M. Diarrhea associated with disinfection of sigmoidoscopes. [abstract]. Am J Infect Control 1991;19:109.
  624. Durante L, Zulty JC, Israel E, et al. Investigation of an outbreak of bloody diarrhea: association with endoscopic cleaning solution and demonstration of lesions in an animal model. Am. J. Med. 1992;92:476-80.
  625. Burtin P, Ruget O, Petit R, Boyer J. Glutaraldehyde-induced proctitis after endorectal ultrasound examination: a higher risk of incidence than expected? Gastrointest. Endosc. 1993;39:859-60.
  626. Babb RR, Paaso BT. Glutaraldehyde proctitis. West. J. Med. 1995;163:477-8.
  627. Ryan CK, Potter GD. Disinfectant colitis. Rinse as well as you wash. J. Clin. Gastroenterol. 1995;21:6-9.
  628. Rozen P, Somjen GJ, Baratz M, Kimel R, Arber N, Gilat T. Endoscope-induced colitis: description, probable cause by glutaraldehyde, and prevention. Gastrointest. Endosc. 1994;40:547-53.
  629. West AB, Kuan SF, Bennick M, Lagarde S. Glutaraldehyde colitis following endoscopy: clinical and pathological features and investigation of an outbreak. Gastroenterology 1995;108:1250-5.
  630. Dolce P, Gourdeau M, April N, Bernard PM. Outbreak of glutaraldehyde-induced proctocolitis. Am. J. Infect. Control 1995;23:34-9.
  631. Farina A, Fievet MH, Plassart F, Menet MC, Thuillier A. Residual glutaraldehyde levels in fiberoptic endoscopes: measurement and implications for patient toxicity. J. Hosp. Infect. 1999;43:293-7.
  632. Dailey JR, Parnes RE, Aminlari A. Glutaraldehyde keratopathy. Am. J. Ophthalmol. 1993;115:256-8.
  633. Courtright P, Lewallen S, Holland SP, Wendt TM. Corneal decompensation after cataract surgery. An outbreak investigation in Asia. Ophthalmology 1995;102:1461-5.
  634. Leinster P, Baum JM, Baxter PJ. An assessment of exposure to glutaraldehyde in hospitals: typical exposure levels and recommended control measures. Br. J. Ind. Med. 1993;50:107-11.
  635. Beauchamp RO, St Clair MB, Fennell TR, Clarke DO, Morgan KT. A critical review of the toxicology of glutaraldehyde. Crit. Rev. Toxicol. 1992;22:143-74.
  636. Corrado OJ, Osman J, Davies RJ. Asthma and rhinitis after exposure to glutaraldehyde in endoscopy units. Hum. Toxicol. 1986;5:325-8.
  637. Norback D. Skin and respiratory symptoms from exposure to alkaline glutaraldehyde in medical services. Scand. J. Work, Environ. Health 1988;14:366-71.
  638. Mwaniki DL, Guthua SW. Occupational exposure to glutaraldehyde in tropical climates. Lancet 1992;340:1476-7.
  639. Centers for Disease Control. Symptoms of irritation associated with exposure to glutaraldehyde. MMWR 1987;36:190-1.
  640. Wiggins P, McCurdy SA, Zeidenberg W. Epistaxis due to glutaraldehyde exposure. J. Occup. Med. 1989;31:854-6.
  641. Di Prima T, De Pasquale R, Nigro M. Contact dermatitis from glutaraldehyde. Contact Dermatitis 1988;19:219-20.
  642. Fowler JF, Jr. Allergic contact dermatitis from glutaraldehyde exposure. J. Occup. Med. 1989;31:852-3.
  643. Fisher AA. Allergic contact dermatitis of the hands from Sporicidin (glutaraldehyde-phenate) used to disinfect endoscopes. Cutis 1990;45:227-8.
  644. Nethercott JR, Holness DL, Page E. Occupational contact dermatitis due to glutaraldehyde in health care workers. Contact Dermatitis 1988;18:193-6.
  645. Gannon PF, Bright P, Campbell M, O'Hickey SP, Burge PS. Occupational asthma due to glutaraldehyde and formaldehyde in endoscopy and x ray departments. Thorax 1995;50:156-9.
  646. Chan-Yeung M, McMurren T, Catonio-Begley F, Lam S. Occupational asthma in a technologist exposed to glutaraldehyde. J. Allergy Clin. Immunol. 1993;91:974-8.
  647. Schnuch A, Uter W, Geier J, Frosch PJ, Rustemeyer T. Contact allergies in healthcare workers. Results from the IVDK. Acta Derm. Venereol. 1998;78:358-63.
  648. Wellons SL, Trawick EG, Stowers MF, Jordan SL, Wass TL. Laboratory and hospital evaluation of four personal monitoring methods for glutaraldehyde in ambient air. Am. Ind. Hyg. Assoc. J. 1998;59:96-103.
  649. Newman MA, Kachuba JB. Glutaraldehyde: a potential health risk to nurses. Gastroenterol. Nurs. 1992;14:296-300, discussion 300-1.
  650. Association for the Advancement of Medical Instrumentation. Safe use and handling of glutaraldehyde-based products in healthcare facilities. Arlington, VA: AAMI, 1995.
  651. Anonymous. Glutaraldehyde. New York: Occupational Health Services, Inc., 1992.
  652. Rutala WA, Hamory BH. Expanding role of hospital epidemiology: employee health--chemical exposure in the health care setting. Infect. Control Hosp. Epidemiol. 1989;10:261-6.
  653. Turner FJ. Hydrogen peroxide and other oxidant disinfectants. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1983:240-50.
  654. Block SS. Peroxygen compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:185-204.
  655. Sattar SA, Springthorpe VS, Rochon M. A product based on accelerated and stabilized hydrogen peroxide: Evidence for broad-spectrum germicidal activity. Canadian J Infect Control 1998 (Winter):123-30.
  656. Omidbakhsh N, Sattar SA. Broad-spectrum microbicidal activity, toxicologic assessment, and materials compatibility of a new generation of accelerated hydrogen peroxide-based environmental surface disinfectant. Am. J. Infect. Control 2006;34:251-7.
  657. Schaeffer AJ, Jones JM, Amundsen SK. Bacterial effect of hydrogen peroxide on urinary tract pathogens. Appl. Environ. Microbiol. 1980;40:337-40.
  658. Wardle MD, Renninger GM. Bactericidal effect of hydrogen peroxide on spacecraft isolates. Appl. Microbiol. 1975;30:710-1.
  659. Sagripanti JL, Bonifacino A. Comparative sporicidal effect of liquid chemical germicides on three medical devices contaminated with spores of Bacillus subtilis. Am. J. Infect. Control 1996;24:364-71.
  660. Sagripanti JL, Bonifacino A. Effects of salt and serum on the sporicidal activity of liquid disinfectants. J. AOAC Int. 1997;80:1198-207.
  661. Saurina G, Landman D, Quale JM. Activity of disinfectants against vancomycin-resistant Enterococcus faecium. Infect. Control Hosp. Epidemiol. 1997;18:345-7.
  662. Kilvington S. Moist-heat disinfection of Acanthamoeba cysts. Rev. Infect. Dis. 1991;13:S418.
  663. Sattar SA, Adegbunrin O, Ramirez J. Combined application of simulated reuse and quantitative carrier test to assess high-level disinfection: Experiments with an accelerated hydrogen peroxide-based formulation. Am. J. Infect. Control 2002;30:449-57.
  664. Leaper S. Influence of temperature on the synergistic sporicidal effect of peracetic acid plus hydrogen peroxide in Bacillus subtilis SA22(NCA 72-52). Food Microbiol. 1984;1:199-203.
  665. Mentel R, Schmidt J. Investigations on rhinovirus inactivation by hydrogen peroxide. Acta Virol. 1973;17:351-4.
  666. Sattar SA. Effect of liquid chemical germicides on mycobacteria including multi-drug resistant isolates of Mycobacteria tuberculosis. Abstracts of the 37th Interscience Conference on Antimicrobial Agents of Chemotherapy; September 28-October 1, 1997; Toronto, Ontario, Canada; E166., 1997.
  667. Reckitt & Colman. Sporox sterilant and high-level disinfectant technical report. Montvale, NJ: Reckitt & Colman, 1997:1-12.
  668. Sattar SA, Taylor YE, Paquette M, Rubino J. In-hospital evaluation of 7.5% hydrogen peroxide as a disinfectant for flexible endoscopes. Can. J. Infect. Control 1996;11:51-4.
  669. Hobson DW, Seal LA. Evaluation of a novel, rapid-acting, sterilizing solution at room temperature. Am. J. Infect. Control 2000;28:370-5.
  670. Anonymous. Hydrogen peroxide, ACS reagent. Vol. 2001: Sigma Product Information Sheet, http://www.sigma.sial.com/sigma/proddata/h0904.htm.
  671. Silvany RE, Dougherty JM, McCulley JP, Wood TS, Bowman RW, Moore MB. The effect of currently available contact lens disinfection systems on Acanthamoeba castellanii and Acanthamoeba polyphaga. Ophthalmology 1990;97:286-90.
  672. Moore MB. Acanthamoeba keratitis and contact lens wear: the patient is at fault. Cornea 1990;9:S33-5; discussion S39-40.
  673. Judd PA, Tomlin PJ, Whitby JL, Inglis TC, Robinson JS. Disinfection of ventilators by ultrasonic nebulisation. Lancet 1968;2:1019-20.
  674. Levenson JE. Corneal damage from improperly cleaned tonometer tips. Arch. Ophthalmol. 1989;107:1117.
  675. Thompson RL, Haley CE, Searcy MA, et al. Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. JAMA 1984;251:747-51.
  676. Bilotta JJ, Waye JD. Hydrogen peroxide enteritis: the "snow white" sign. Gastrointest. Endosc. 1989;35:428-30.
  677. Gottardi W. Iodine and iodine compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1991:152-66.
  678. Gottardi W. Iodine and iodine compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:159-84.
  679. Craven DE, Moody B, Connolly MG, Kollisch NR, Stottmeier KD, McCabe WR. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N. Engl. J. Med. 1981;305:621-3.
  680. Berkelman RL, Lewin S, Allen JR, et al. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann. Intern. Med. 1981;95:32-6.
  681. Parrott PL, Terry PM, Whitworth EN, et al. Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet 1982;2:683-5.
  682. Favero MS. Iodine--champagne in a tin cup. Infect. Control 1982;3:30-2.
  683. Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J. Clin. Microbiol. 1982;15:635-9.
  684. Chang SL. Modern concept of disinfection. J. Sanit. Eng. Div. Proc. Am. Soc. Civ. Eng. 1971:689-705.
  685. Wallbank AM, Drulak M, Poffenroth L, Barnes C, Kay C, Lebtag I. Wescodyne: lack of activity against poliovirus in the presence of organic matter. Health Lab. Sci. 1978;15:133-7.
  686. Carson JA, Favero MS. Comparative resistance of nontuberculous mycobacteria to iodophor germicides. Abstracts of the Annual Meeting of the American Society for Microbiology, 1984:Q101, p.221.
  687. Medcom. Medcom Frequently Asked Questions. www.medcompnet.com/faq/faq/html, 2000.
  688. Simons C, Walsh SE, Maillard JY, Russell AD. A note: ortho-phthalaldehyde: proposed mechanism of action of a new antimicrobial agent. Lett. Appl. Microbiol. 2000;31:299-302.
  689. Walsh SE, Maillard JY, Simons C, Russell AD. Studies on the mechanisms of the antibacterial action of ortho-phthalaldehyde. J. Appl. Microbiol. 1999;87:702-10.
  690. Fraud S, Hann AC, Maillard J-Y, Russell AD. Effects of ortho-phthalaldehyde, glutaraldehyde and chlorhexidine diacetate on Mycobacterium chelonae and Mycobacterium abscessus strains with modified permeability. J. Antimicrob. Chemother. 2003;51:575-84.
  691. Cabrera-Martinez RM, Setlow B, Setlow P. Studies on the mechanisms of the sporicidal action of ortho-phthalaldehyde. J. Appl. Microbiol. 2002;92:675-80.
  692. Gordon MD, Ezzell RJ, Bruckner NI, Ascenzi JM. Enhancement of mycobactericidal activity of glutaraldehyde with α,ß-unsaturated and aromatic aldehydes. J. Indust. Microbiol. 1994;13:77-82.
  693. Gregory AW, Schaalje GB, Smart JD, Robison RA. The mycobactericidal efficacy of ortho-phthalaldehyde and the comparative resistances of Mycobacterium bovis, Mycobacterium terrae, and Mycobacterium chelonae. Infect. Control Hosp. Epidemiol. 1999;20:324-30.
  694. Walsh SE, Maillard JY, Russell AD. Ortho-phthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J. Appl. Microbiol. 1999;86:1039-46.
  695. Roberts CG, Chan Myers H. Mycobactericidal activity of dilute ortho-phthalaldehyde solutions. In: Abstracts in Environmental and General Applied Microbiology, Q-265, ASM 98th General Meeting, Atlanta, Georgia, USA, 1998:464-5.
  696. Chan-Myers H. Sporicidal activity of ortho-phthalaldehyde as a function of temperature (abstract). Infect. Control Hosp. Epidemiol. 2000;21:101.
  697. Chan-Myers H, Roberts C. Effect of temperature and organic soil concentration on biocidal activity of ortho-phthalaldehyde solution (abstract). 2000 Education Meeting of the Association for Professional in Infection Control and Epidemiology, Minneapolis, MN, 2000:31.
  698. Bruckner NI, Gordon MD, Howell RG. Odorless aromatic dialdehyde disinfecting and sterilizing composition. US Patent 4,851,449. July, 1989.
  699. McDonnell G, Pretzer D. New and developing chemical antimicrobials. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:431-43.
  700. Fraud S, Maillard J-Y, Russell AD. Comparison of the mycobactericidal activity of ortho-phthalaldehyde, glutaraldehyde, and other dialdehydes by a quantitative suspension test. J. Hosp. Infect. 2001;48:214-21.
  701. Sattar SA, Springthorpe VS. New methods for efficacy testing of disinfectants and antiseptics. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:174-86.
  702. Walsh SE, Maillard J-Y, Russell AD, Hann AC. Possible mechanisms for the relative efficiacies of ortho-phthalaldehyde and glutaraldehyde aganst glutaradehyde-resistant Mycobacterium chelonae. J. Appl. Microbiol. 2001;91:80-92.
  703. Herruzo-Cabrera R, Vizcaino-Alcaide MJ, Rodriquez J. Comparison of the microbicidal efficacy on germ carriers of several tertiary amine compounds with ortho-phthalaldehyde and Perasafe. J. Hosp. Infect. 2006;63:73-8.
  704. Herruzo-Cabrera R, Vizcaino-Alcaide MJ, Fernandez-Acenero MJ. The influence of laboratory adaptation on test strains, such as Pseudomonas aeruginosa, in the evaluation of the antimicrobial efficacy of ortho-phthalaldehyde. J. Hosp. Infect. 2004;57:217-22.
  705. Favero MS. Naturally occurring microorganisms and their resistance to physical and chemical agents. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington, DC: Association for Professionals in Infection Control and Epidemiology, 2004:1-15.
  706. Cooke RPD, Goddard SV, Whymant-Morris A, Sherwood J, Chatterly R. An evaluation of Cidex OPA (0.55% ortho-phthalaldehyde) as an alternative to 2% glutaraldehyde for high-level disinfection of endoscopes. J. Hosp. Infect. 2003;54:226-31.
  707. Streckenbach SC, Alston TA. Perioral stains after ortho-phthalaldehyde disinfectioon of echo probes. Anesthesiol 2003;99:1032.
  708. Wardle E, Jones D. Determination of rinsing volumes following manual endoscope disinfection with ortho-phthalaldehyde (OPA). J Gastroenterol Nurses College Australia 2003;January:7-9.
  709. Sokol WN. Nine episodes of anaphylaxis following cytoscopy caused by Cidex OPA (ortho-phthalaldehyde) high-level disinfectant in 4 patients after cystoscopy. J. Allergy Clin. Immunol. 2004;114:392-7.
  710. Hession SM. Endoscopic disinfection by ortho-phthalaldehyde in a clinical setting: An evaluation of reprocessing time and costs compared with glutaraldehyde. Gastroenterol. Nurs. 2003;26:110-4.
  711. Tucker RC, Lestini BJ, Marchant RE. Surface analysis of clinically used expanded PTFE endoscopic tubing treated by the STERIS PROCESS. ASAIO J. 1996;42:306-13.
  712. Hernandez A, Martro E, Matas L, Ausina V. In-vitro evaluation of Pearsafe compared with 2% alkaline glutaraldehyde against Mycobacterium spp. J. Hosp. Infect. 2003;54:52-6.
  713. Vizcaino-Alcaide MJ, Herruzo-Cabrera R, Fernandez-Acenero MJ. Comparison of the disinfectant efficacy of Persafe and 2% glutaraldehyde in in vitro tests. J. Hosp. Infect. 2003;53:124-8.
  714. Lensing HH, Oei HL. Investigations on the sporicidal and fungicidal activity of disinfectants. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene - 1 - Abt - Originale B, Hygiene 1985;181:487-95.
  715. Sagripanti JL, Bonifacino A. Comparative sporicidal effects of liquid chemical agents. Appl. Environ. Microbiol. 1996;62:545-51.
  716. Crow S. Peracetic acid sterilization: a timely development for a busy healthcare industry. Infect. Control Hosp. Epidemiol. 1992;13:111-3.
  717. Malchesky PS. Medical applications of peracetic acid. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:979-96.
  718. Mannion PT. The use of peracetic acid for the reprocessing of flexible endoscopes and rigid cystoscopes and laparoscopes. J. Hosp. Infect. 1995;29:313-5.
  719. Bradley CR, Babb JR, Ayliffe GA. Evaluation of the Steris System 1 Peracetic Acid Endoscope Processor. J. Hosp. Infect. 1995;29:143-51.
  720. Duc DL, Ribiollet A, Dode X, Ducel G, Marchetti B, Calop J. Evaluation of the microbicidal efficacy of Steris System I for digestive endoscopes using GERMANDE and ASTM validation protocols. J. Hosp. Infect. 2001;48:135-41.
  721. Alfa MJ, Olson N, Degagne P, Hizon R. New low temperature sterilization technologies: microbicidal activity and clinical efficacy. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:67-78.
  722. Alfa MJ, DeGagne P, Olson N, Hizon R. Comparison of liquid chemical sterilization with peracetic acid and ethylene oxide sterilization for long narrow lumens. Am. J. Infect. Control 1998;26:469-77.
  723. Seballos RJ, Walsh AL, Mehta AC. Clinical evaluation of a liquid chemical sterilization system for flexible bronchoscopes. J. Bronch. 1995;2:192-99.
  724. Wallace CG, Agee PM, Demicco DD. Liquid chemical sterilization using peracetic acid. An alternative approach to endoscope processing. ASAIO J. 1995;41:151-4.
  725. Centers for Disease Control and Prevention. Bronchoscopy-related infections and pseudoinfections - New York, 1996 and 1998. MMWR 1999;48:557-60.
  726. Middleton AM, Chadwick MV, Gaya H. Disinfection of bronchoscopes, contaminated in vitro with Mycobacterium tuberculosis, Mycobacterium avium-intracellulare and Mycobacterium chelonae in sputum, using stabilized, buffered peracetic acid solution ('Nu-Cidex'). J. Hosp. Infect. 1997;37:137-43.
  727. Holton J, Shetty N. In-use stability of Nu-Cidex. J. Hosp. Infect. 1997;35:245-8.
  728. Alasri A, Roques C, Michel G, Cabassud C, Aptel P. Bactericidal properties of peracetic acid and hydrogen peroxide, alone and in combination, and chlorine and formaldehyde against bacterial water strains. Can. J. Microbiol. 1992;38:635-42.
  729. Stanley P. Destruction of a glutaraldehyde-resistant mycobacterium by a per-oxygen disinfectant. (Abstract). Am. J. Infect. Control 1998;26:185.
  730. Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V. Dialyser reprocessing with Renalin. Am. J. Nephrol. 1991;11:27-31.
  731. Kahn G. Depigmentation caused by phenolic detergent germicides. Arch. Dermatol. 1970;102:177-87.
  732. Prindle RF. Phenolic compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1983:197-224.
  733. Hegna IK. A comparative investigation of the bactericidal and fungicidal effects of three phenolic disinfectants. J. Appl. Bacteriol. 1977;43:177-81.
  734. Hegna IK. An examination of the effect of three phenolic disinfectants on Mycobacterium tuberculosis. J. Appl. Bacteriol. 1977;43:183-7.
  735. Bergan T, Lystad A. Antitubercular action of disinfectants. J. Appl. Bacteriol. 1971;34:751-6. 736.
  736. Narang HK, Codd AA. Action of commonly used disinfectants against enteroviruses. J. Hosp. Infect. 1983;4:209-12.
  737. Cole EC, Rutala WA, Samsa GP. Disinfectant testing using a modified use-dilution method: collaborative study. J. Assoc. Off. Anal. Chem. 1988;71:1187-94.
  738. Goddard PA, McCue KA. Phenolic compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:255-81.
  739. Wysowski DK, Flynt JW, Jr., Goldfield M, Altman R, Davis AT. Epidemic neonatal hyperbilirubinemia and use of a phenolic disinfectant detergent. Pediatrics 1978;61:165-70.
  740. Doan HM, Keith L, Shennan AT. Phenol and neonatal jaundice. Pediatrics 1979;64:324-5.
  741. Shickman MD, Guze LB, Pearce ML. Bacteremia following cardiac catheterization. N. Engl. J. Med. 1959;260:1164-6.
  742. Ehrenkranz NJ, Bolyard EA, Wiener M, Cleary TJ. Antibiotic-sensitive Serratia marcescens infections complicating cardiopulmonary operations: contaminated disinfectant as a reservoir. Lancet 1980;2:1289-92.
  743. Shere L. Some comparisons of the disinfecting properties of hypochlorites and quaternary ammonium compounds. Milk Plant Monthly March 1948:66-9.
  744. MacDougall KD, Morris C. Optimizing disinfectant application in healthcare facilities. Infect Control Today 2006;June:62-7.
  745. Sykes G. Disinfection and sterilization. London: E & FN Spon Ltd, 1965.
  746. Merianos JJ. Surface-active agents. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:283-320.
  747. Purohit A, Kopferschmitt-Kubler MC, Moreau C, Popin E, Blaumeiser M, Pauli G. Quaternary ammonium compounds and occupational asthma. International Archives of Occupational & Environmental Health 2000;73:423-7.
  748. Petrocci AN. Surface active agents: quaternary ammonium compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1983:309-29.
  749. Smith CR, Nishihara H, Golden F, Hoyt A, Guss CO, Kloetzel MC. The bactericidal effect of surface-active agents on tubercle bacilli. Public Health Rep. 1950;48:1588-1600.
  750. Broadley SJ, Furr JR, Jenkins PA, Russell AD. Antimycobacterial activity of 'Virkon'. J. Hosp. Infect. 1993;23:189-97.
  751. Angelillo IF, Bianco A, Nobile CG, Pavia M. Evaluation of the efficacy of glutaraldehyde and peroxygen for disinfection of dental instruments. Lett. Appl. Microbiol. 1998;27:292-6.
  752. Coates D. Disinfectants and spills of body fluids. Nurs. RSA 1992;7:25-7.
  753. Hamouda T, Hayes MM, Cao ZH, et al. A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J. Infect. Dis. 1999;180:1939-49.
  754. Hamouda T, Myc A, Donovan B, Shih AY, Reuter JD, Baker JR. A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi. Microbiol. Res. 2001;156:1-7.
  755. Hamouda T, Baker JR, Jr. Antimicrobial mechanism of action of surfactant lipid preparations in enteric Gram-negative bacilli. J. Appl. Microbiol. 2000;89:397-403.
  756. Widmer AF, Frei R. Antimicrobial activity of glucoprotamin: A clinical study of a new disinfectant for instruments. Infect Control Hosp Epidemiol 2003;24:762-4.
  757. Wilson M. Light-activated antimicrobial coating for the continuous disinfection of surfaces. Infect Control Hosp Epidemiol 2003;24:782-4.
  758. Schneider PM. New technologies for disinfection and sterilization. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington DC: Association for Professionals in Infection Control and Epidemiology, 2004:127-39.
  759. Rotter ML. Handwashing, hand disinfection, and skin disinfection. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams and Wilkins, 1997:691-709.
  760. Mandel GL, Bennett JE, Dolin R. Principles and practices of infectious diseases. New York: Livingstone, 2000.
  761. Weber DJ, Rutala WA. Use of metals and microbicides in the prevention of nosocomial infections. In: Rutala W, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1995:271-85.
  762. Weber DJ, Rutala WA. Use of metals as microbicides in preventing infections in healthcare. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:415-30.
  763. Brady MJ, Lisay CM, Yurkovetskiy AV, Sawan SP. Persistent silver disinfectant for the environmental control of pathogenic bacteria. Am. J. Infect. Control 2003;31:208-214.
  764. Rusin P, Bright K, Gerba C. Rapid reduction of Legionella pneumophila on stainless steel with zeolite coatings containing silver and zinc ions. Lett. Appl. Microbiol. 2003;36:69-72.
  765. Bright KR, Gerba CP, Rusin PA. Rapid reduction of Staphylococcus aureus populations on stainless stell surfaces by zeolite ceramic coatings containing silver and zinc ions. J. Hosp. Infect. 2002;52:307-9.
  766. Landeen LK, Yahya MT, Gerba CP. Efficacy of copper and silver ions and reduced levels of free chlorine in inactivation of Legionella pneumophila. Appl. Environ. Microbiol. 1989;55:3045-50.
  767. Pyle BH, Broadaway SC, McFeters GA. Efficacy of copper and silver ions with iodine in the inactivation of Pseudomonas cepacia. J. Appl. Bacteriol. 1992;72:71-9.
  768. Yahya MT, Landeen LK, Messina MC, Kutz SM, Schulze R, Gerba CP. Disinfection of bacteria in water systems by using electrolytically generated copper:silver and reduced levels of free chlorine. Can. J. Microbiol. 1990;36:109-16.
  769. Liu Z, Stout JE, Tedesco L, et al. Controlled evaluation of copper-silver ionization in eradicating Legionella pneumophila from a hospital water distribution system. J. Infect. Dis. 1994;169:919-22.
  770. Noyce JO, Michels H, Keevil CW. Potential use of copper surfaces to reduce survival of epidemic methicillin-resistant Staphylococcus aureus in the healthcare environment. J. Hosp. Infect. 2006;63:289-97.
  771. Goetz A, Yu VL. Copper-silver ionization: cautious optimism for Legionella disinfection and implications for environmental culturing. Am. J. Infect. Control 1997;25:449-51.
  772. Miuetzner S, Schwille RC, Farley A, et al. Efficacy of thermal treatment and copper-silver ionization for controlling Legionella pneumophila in high-volume hot water plumbing systems in hospitals. Am. J. Infect. Control 1997;25:452-7.
  773. Stout JE, Lin YS, Goetz AM, Muder RR. Controlling Legionella in hospital water systems: experience with the superheat-and-flush method and copper-silver ionization. Infect. Control Hosp. Epidemiol. 1998;19:911-4.774.
  774. Stout JE, Yu VL. Experience of the first 16 hospitals using copper-silver ionization for Legionella control: Implications for the evaluation of other disinfection modalities. Infect Control Hosp Epidemiol 2003;24:563-8.
  775. Russell AD. Ultraviolet radiation. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and practices of disinfection, preservation and sterilization. Oxford: Blackwell Science, 1999:688-702.
  776. Hall KK, Giannetta ET, Getchell-White SI, Durbin LJ, Farr BM. Ultraviolet light disinfection of hospital water for preventing nosocomial Legionella infection: A 13-year follow-up. Infect Control Hosp Epidemiol 2003;24:580-3.
  777. Singh S, Schaaf NG. Dynamic sterilization of titanium implants with ultraviolet light. Internat. J. Oral Maxillofac. Implants 1989;4:139-46.
  778. Dolman PJ, Dobrogowski MJ. Contact lens disinfection by ultraviolet light. Am. J. Ophthalmol. 1989;108:665-9.
  779. Shechmeister IL. Sterilization by ultraviolet irradiation. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1991:553-65.
  780. National Research Council. Postoperative wound infections - the influence of ultraviolet irradiation of the operating room and of various other factors. Ann. Surg. 1964;160:1-125.
  781. Sensakovic JW, Smith LG. Nosocomial ultraviolet keratoconjunctivitis. Infect. Control 1982;3:475-6.
  782. Cefai C, Richards J, Gould FK, McPeake P. An outbreak of respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J. Hosp. Infect. 1990;15:177-82.
  783. Gurevich I, Tafuro P, Ristuccia P, Herrmann J, Young AR, Cunha BA. Disinfection of respirator tubing: a comparison of chemical versus hot water machine-assisted processing. J. Hosp. Infect. 1983;4:199-208.
  784. Rutala WA, Weber DJ, Gergen MF, Gratta AR. Efficacy of a washer-pasteurizer for disinfection of respiratory-care equipment. Infect. Control Hosp. Epidemiol. 2000;21:333-6.
  785. Jette LP, Lambert NG. Evaluation of two hot water washer disinfectors for medical instruments. Infect. Control Hosp. Epidemiol. 1988;9:194-9.
  786. Wang C-Y, Wu H-D, Lee L-N, et al. Pasteurization is effective against multidrug-resistant bacteria. Am. J. Infect. Control 2006;34:320-2.
  787. Dempsey KM, Chiew RF, McKenzie JA, Mitchell DH. Evaluation of the cleaning and disinfection efficacy of the DEKO-190; award-based automated washer/disinfector. J. Hosp. Infect. 2000;46:50-4.
  788. Kearns AM, Freeman R, Lightfoot NF. Nosocomial enterococci: resistance to heat and sodium hypochlorite. J. Hosp. Infect. 1995;30:193-9.
  789. Bradley CR, Fraise AP. Heat and chemical resistance of enterococci. J. Hosp. Infect. 1996;34:191-6.
  790. Chadwick PR, Oppenheim BA. Vancomycin-resistant enterococci and bedpan washer machines. Lancet 1994;344:685.
  791. Nystrom B. New technology for sterilization and disinfection. Am. J. Med. 1991;91:264S-266S.
  792. Sanders FT, Morrow MS. The EPA's role in the regulation of antimicrobial pesticides in the United States. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington, DC: Association for Professionals in Infection Control and Epidemiology, 2004:29-41.
  793. Anonymous. Memorandum of understanding between the Food and Drug Administration, Public Health Service, and the Environmental Protection Agency, 1993.
  794. Ulatowski TA. Current activities concerning the premarket evaluation of infection control devices at the Food and Drug Administration. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:1-7.
  795. Cole EC, Rutala WA. Bacterial numbers on penicylinders used in disinfectant testing: use of 24 hour adjusted broth cultures. J. Assoc. Off. Anal. Chem. 1988;71:9-11.
  796. Cole EC, Rutala WA, Alfano EM. Comparison of stainless steel penicylinders used in disinfectant testing. J. Assoc. Off. Anal. Chem. 1988;71:288-9.
  797. Cole EC, Rutala WA, Carson JL. Evaluation of penicylinders used in disinfectant testing: bacterial attachment and surface texture. J. Assoc. Off. Anal. Chem. 1987;70:903-6.
  798. Cole EC, Rutala WA, Samsa GP. Standardization of bacterial numbers of penicylinders used in disinfectant testing: interlaboratory study. J. Assoc. Off. Anal. Chem. 1987;70:635-7.
  799. Alfano EM, Cole EC, Rutala WA. Quantitative evaluation of bacteria washed from stainless steel penicylinders during AOAC use-dilution method. J. Assoc. Off. Anal. Chem. 1988;71:868-71.
  800. Favero MS, Groschel DHM. Chemical germicides in the health care field: current status and evaluation of efficacy and research needs. Washington, DC: American Society for Microbiology, 1987.
  801. Sattar SA. Microbicidal testing of germicides: an update. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:227-40.
  802. Best M. Development of a combined carrier test for disinfectant efficacy. Ottawa, Canada: University of Ottawa, 1994.
  803. Sattar SA, Springthorpe VS. Recent developments in methods for testing the germicidal activity of disinfectants and antiseptics. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington, DC: Association for Professionals in Infection Control and Epidemiology, 2004:180-8.
  804. Sanders FT. Environmental protection agency's role in the regulation of antimicrobial pesticides in the United States. In: Rutala WA, ed. Disinfection, Sterilization and Antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:28-40.
  805. Groschel DHM. Caveat emptor: do your disinfectants work? Infect. Control 1983;4:144.
  806. United States General Accounting Office. Disinfectants: EPA lacks assurance they work., 1990.
  807. Johnston MD, Lambert RJW, Hanlon GW, Denyer SP. A rapid method for assessing the suitability of quenching agents for individual biocides as well as combinations. J. Appl. Microbiol. 2002;92:784-9.
  808. Russell AD. Neutralization procedures in the evaluation of bactericidal activity. In: Collins CH, Allwood MC, Bloomfield SF, Fox A, eds. Disinfectants: their use and evaluation of effectiveness. London: Academic Press, 1981:45-59.
  809. Russell AD, Ahonkhai I, Rogers DT. Microbiological applications of the inactivation of antibiotics and other antimicrobial agents. J. Appl. Bacteriol. 1979;46:207-45.
  810. Engley FB, Jr, Dey BP. A universal neutralizing medium for antimicrobial chemicals. Chem. Specialists Manuf. Assoc. Proc. 1970:100-6.
  811. Association for the Advancement of Medical Instrumentation. Good hospital practice: Steam sterilization and sterility assurance. AAMI. Arlington, VA, 1993.
  812. Association for the Advancement of Medical Instrumentation. Flash sterilization: Steam sterilization of patient care items for immediate use. AAMI. Arlington, VA, 1996.
  813. Association for the Advancement of Medical Instrumentation. Steam sterilization and sterility assurance in health care facilities. ANSI/AAMI ST46. Arlington, VA, 2002:ANSI/AAMI ST46:2002.
  814. Association for the Advancement of Medical Instrumentation. Ethylene oxide sterilization in health care facilities: Safety and effectiveness. AAMI. Arlington, VA, 1999.
  815. Association of Operating Room Nurses. Recommended practices for sterilization in perioperative practice settings. 2000 Standards, Recommended Practices, and Guidelines. Denver, CO: AORN, 2000:347-58.
  816. Association for peri-Operative Registered Nurses. Recommended practices for cleaning and caring for surgical instruments and powered equipment. AORN J. 2002;75:727-41.
  817. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect. Control Hosp. Epidemiol. 1999;20:250-78.
  818. Education Design. Best practices for the prevention of surgical site infection. Denver Colorado: Education Design, 1998.
  819. Association for the Advancement of Medical Instrumentation. Comprehensive guide to steam sterilization and sterility assurance in health care facilities, ANSI/AAMI ST79. 2006.
  820. Association for peri-Operative Registered Nurses. Recommended pracice for sterilization in the perioperative practice setting. AORN J. 2006;83:700-22.
  821. Singh J, Bhatia R, Gandhi JC, et al. Outbreak of viral hepatitis B in a rural community in India linked to inadequately sterilized needles and syringes. Bull. World Health Organ. 1998;76:93-8.
  822. Eickhoff TC. An outbreak of surgical wound infections due to Clostridium perfringens. Surg. Gynecol. Obstet. 1962;114:102-8.
  823. Favero MS. Sterility assurance: Concepts for patient safety. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:110-9.
  824. Oxborrow GS, Berube R. Sterility testing-validation of sterilization processes, and sporicide testing. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1991:1047-57.
  825. Rutala WA, Weber DJ. Clinical effectiveness of low-temperature sterilization technologies. Infect. Control Hosp. Epidemiol. 1998;19:798-804.
  826. Adler S, Scherrer M, Daschner FD. Costs of low-temperature plasma sterilization compared with other sterilization methods. J. Hosp. Infect. 1998;40:125-34.
  827. Joslyn L. Sterilization by heat. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:695-728.
  828. Bucx MJ, Veldman DJ, Beenhakker MM, Koster R. The effect of steam sterilization at 134 degrees C on light intensity provided by fibrelight Macintoch laryngoscopes. Anaesthesia 2000;55:185-6.
  829. Gilbert JA, Phillips HO. The effect of steam sterilization on plaster casting material. Clinical Orthopaed Rel Res 1984:241-4.
  830. Agalloco JP, Akers JE, Madsen RE. Moist heat sterilization--myths and realities. PDA J. Pharmaceutical Sci. Technol. 1998;52:346-50.
  831. Rutala WA, Stiegel MM, Sarubbi FA, Jr. Decontamination of laboratory microbiological waste by steam sterilization. Appl. Environ. Microbiol. 1982;43:1311-6.
  832. Lauer JL, Battles DR, Vesley D. Decontaminating infectious laboratory waste by autoclaving. Appl. Environ. Microbiol. 1982;44:690-4.
  833. Rhodes P, Zelner L, Laufman H. A new disposable bowie-Dick-type test pack for prevacuum high-temperature sterilizers. Med. Instrum. 1982;16:117-20.
  834. Association for the Advancement of Medical Instrumentation. Technical Information Report on process challenge devices/test packs for use in health care facilities, 2003.
  835. Young M. Sterilization process monitoring. Managing Infect Control 2004;August:70-6.
  836. American Society for Healthcare Central Service Professionals. Training Manual for Health Care Central Service Technicians. In: Association AH, ed. Chicago: The Jossey-Bass/American Hospital Association Press Series, 2001:1-271.
  837. Crow S. Steam sterilizers: an evolution in design. Infect. Control Hosp. Epidemiol. 1993;14:488-90.
  838. Gurevich I, Jacobsen E, Cunha BA. Pseudoautoclave failure caused by differences in spore test steam sensitivities. Am. J. Infect. Control 1996;24:402-4.
  839. Bryce EA, Roberts FJ, Clements B, MacLean S. When the biological indicator is positive: investigating autoclave failures. Infect. Control Hosp. Epidemiol. 1997;18:654-6.
  840. Barone MA, Faisel AJ, Andrews L, Ahmed J, Rashida B, Kristensen D. Adaptation and validation of a portable steam sterilizer for processing intrauterine device insertion instruments and supplies in low-resource settings. Am. J. Infect. Control 1997;25:350-6.
  841. Young JH. Sterilization with steam under pressure. In: Morrissey RF, Phillips GB, eds. Sterilization technology: a practical guide for manufacturers and users of health care product. New York: Van Nostrand Reinhold, 1993:81-119.
  842. Palenik CJ, Cumberlander ND. Effects of steam sterilization on the contents of sharps containers. Am. J. Infect. Control 1993;21:28-33.
  843. Rutala WA. Disinfection and flash sterilization in the operating room. J. Ophthal. Nurs. Technol. 1991;10:106-15.
  844. Maki DG, Hassemer CA. Flash sterilization: carefully measured haste. Infect. Control 1987;8:307-10.
  845. Barrett T. Flash sterilization: What are the risks? In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:70-6.
  846. Vesley D, Langholz AC, Rohlfing SR, Foltz WE. Fluorimetric detection of a Bacillus stearothermophilus spore-bound enzyme, α-D-glucosidase, for rapid identification of flash sterilization failure. Appl. Environ. Microbiol. 1992;58:717-9.
  847. Rutala WA, Gergen MF, Weber DJ. Evaluation of a rapid readout biological indicator for flash sterilization with three biological indicators and three chemical indicators. Infect. Control Hosp. Epidemiol. 1993;14:390-4.
  848. Strzelecki LR, Nelson JH. Evaluation of closed container flash sterilization system. Orthoped. Nurs. 1989;8:21-4.
  849. Hood E, Stout N, Catto B. Flash sterilization and neurosurgical site infections: Guilt by association. Am. J.Infect. Control 1997;25:156.
  850. Rutala WA, Weber DJ, Chappell KJ. Patient injury from flash-sterilized instruments. Infect. Control Hosp. Epidemiol. 1999;20:458.
  851. Schneider PM. Low-temperature sterilization alternatives in the 1990s. Tappi J. 1994;77:115-9.
  852. Environmental Protection Agency. Protection of stratospheric ozone; Proposed Rule. 40 CFR Part 82. Fed. Regist. 1993.
  853. Schneider PM. Emerging low temperature sterilization technologies (non-FDA approved). In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:79-92.
  854. Gross D. Ethylene oxide sterilization and alternative methods. Surg. Serv. Management 1995;1:16-7.
  855. Holler C, Martiny H, Christiansen B, Ruden H, Gundermann KO. The efficacy of low temperature plasma (LTP) sterilization, a new sterilization technique. Zentralbl. Hyg. Umweltmed. 1993;194:380-91.
  856. Rutala WA, Gergen MF, Weber DJ. Comparative evaluation of the sporicidal activity of new low-temperature sterilization technologies: ethylene oxide, 2 plasma sterilization systems, and liquid peracetic acid. Am. J. Infect. Control 1998;26:393-8.
  857. Ernst RR, Doyle JE. Sterilization with gaseous ethylene oxide: a review of chemical and physical factors. Biotech. Bioeng. 1968;10.
  858. Joslyn L. Gaseous chemical sterilization. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:337-60.
  859. Fisher AA. Ethylene oxide dermatitis. Cutis 1984;34:20, 22, 24.
  860. Jay WM, Swift TR, Hull DS. Possible relationship of ethylene oxide exposure to cataract formation. Am. J. Ophthalmol. 1982;93:727-32.
  861. Salinas E, Sasich L, Hall DH, Kennedy RM, Morriss H. Acute ethylene oxide intoxication. Drug Intell. Clin. Pharm. 1981;15:384-6.
  862. Marchand M, Delesvonx R, Claeys C. The toxicity of ethylene oxide and a report on three fatal cases of poisoning. Am. Arch. Indust. Health 1958;18:60.
  863. Finelli PF, Morgan TF, Yaar I, Granger CV. Ethylene oxide-induced polyneuropathy. A clinical and electrophysiologic study. Arch. Neurol. 1983;40:419-21.
  864. Estrin WJ, Becker CE. Evidence of neurologic dysfunction related to long-term ethylene oxide exposure. Arch. Neurol. 1987;44:1283-6.
  865. Estrin WJ, Bowler RM, Lash A, Becker CE. Neurotoxicological evaluation of hospital sterilizer workers exposed to ethylene oxide. J. Toxicol. Clin. Toxicol. 1990;28:1-20.
  866. Crystal HA, Schaumburg HH, Grober E, Fuld PA, Lipton RB. Cognitive impairment and sensory loss associated with chronic low-level ethylene oxide exposure. Neurology 1988;38:567-9.
  867. Shaham J, Levi Z, Gurvich R, Shain R, Ribak J. Hematological changes in hospital workers due to chronic exposure to low levels of ethylene oxide. J. Occup. Environ. Med. 2000;42:843-50.
  868. Lindbohm ML, Hemminki K, Bonhomme MG, et al. Effects of paternal occupational exposure on spontaneous abortions. Am. J. Public Health 1991;81:1029-33.
  869. Hemminki K, Mutanen P, Saloniemi I, Niemei M-L, Vainio H. Spontaneous abortions in hospital staff engaged in sterilising instruments with chemical agents. Br. Med. J. 1982;285:1461-3.
  870. Rowland AS, Baird DD, Shore DL, Darden B, Wilcox AJ. Ethylene oxide exposure may increase the risk of spontaneous abortion, preterm birth, and postterm birth. Epidemiology 1996;7:363-8.
  871. National Toxicology Program. http://ntp-server.niehs.nih.gov/.
  872. Anonymous. Ethylene oxide sterilization: How hospitals can adapt to the changes. Health Devices 1994;23:485-92.
  873. Occupational Safety and Health Administration. Ethylene Oxide: OSHA Fact Sheet: Occupational Safety and Health Administration, 2002.
  874. Cardenas-Camarena L. Ethylene oxide burns from improperly sterilized mammary implants. Ann. Plast. Surg. 1998;41:361-9.
  875. Windebank AJ, Blexrud MD. Residual ethylene oxide in hollow fiber hemodialysis units is neurotoxic in vitro. Ann. Neurol. 1989;26:63-8.
  876. Occupational Health and Safety Administration. Chemical sampling information-Ethylene chlorohydrin: Occupational Safety and Health Administration, 2002.
  877. Parisi AN, Young WE. Sterilization with ethylene oxide and other gases. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lea & Febiger, 1991:580-95.
  878. Ries MD, Weaver K, Beals N. Safety and efficacy of ethylene oxide sterilized polyethylene in total knee arthroplasty. Clin. Orthop. 1996:159-63.
  879. Alfa MJ, DeGagne P, Olson N. Bacterial killing ability of 10% ethylene oxide plus 90% hydrochlorofluorocarbon sterilizing gas. Infect. Control Hosp. Epidemiol. 1997;18:641-5.
  880. Parker HH, Johnson RB. Effectiveness of ethylene oxide for sterilization of dental handpieces. J. Dent. 1995;23:113-5.
  881. Jacobs PT, Lin SM. Sterilization processes utilizing low-temperature plasma. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:747-63.
  882. Rutala WA, Gergen MF, Weber DJ. Sporicidal activity of a new low-temperature sterilization technology: the Sterrad 50 sterilizer. Infect. Control Hosp. Epidemiol. 1999;20:514-6.
  883. Kyi MS, Holton J, Ridgway GL. Assessment of the efficacy of a low temperature hydrogen peroxide gas plasma sterilization system. J. Hosp. Infect. 1995;31:275-84.
  884. Jacobs PT, Smith D. The new Sterrad 100S sterilization system: Features and advantages. Zentr. Steril. 1998;6:86-94.
  885. Rudolph H, Hilbert M. Practical testing of the new plasma sterilizer "Sterrad 100S" in the Diakonkrankenhaus Rotenburg. Zentr. Steril. 1997;5:207-15.
  886. Bar W, Marquez de Bar G, Naumann A, Rusch-Gerdes S. Contamination of bronchoscopes with Mycobacterium tuberculosis and successful sterilization by low-temperature hydrogen peroxide plasma sterilization. Am. J. Infect. Control 2001;29:306-11.
  887. Centers for Disease Control and Prevention. Corneal decompensation after intraocular ophthalmic surgery-Missouri, 1998. MMWR 1998;47:306-9.
  888. Duffy RE, Brown SE, Caldwell KL, et al. An epidemic of corneal destruction caused by plasma gas sterilization. Arch. Ophthalmol. 2000;118:1167-76.
  889. Jarvis WR. Hospital Infections Program, Centers for Disease Control and Prevention: On-site outbreak investigations, 1990-1999: How often are germicides or sterilants the source? In: Rutala WA, ed. Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities. Washington, DC: Association for Professional in Infection Control and Epidemiology, 2001:41-8.
  890. Borneff M, Ruppert J, Okpara J, et al. Efficacy testing of low-temperature plasma sterilization (LTP) with test object models simulating practice conditions. Zentr. Steril. 1995;3:361-71.
  891. Borneff-Lipp M, Okpara J, Bodendorf M, Sonntag HG. Validation of low-temperature-plasma (LPT) sterilization systems: Comparison of two technical versions, the Sterrad 100, 1.8 and the 100S. Hygiene und Mikrobiologie 1997;3:21-8.
  892. Roberts C, Antonoplos P. Inactivation of human immunodeficiency virus type 1, hepatitis A virus, respiratory syncytial virus, vaccinia virus, herpes simplex virus type 1, and poliovirus type 2 by hydrogen peroxide gas plasma sterilization. Am. J. Infect. Control 1998;26:94-101.
  893. Okpara-Hofmann J, Knoll M, Durr M, Schmitt B, Borneff-Lipp M. Comparison of low-temperature hydrogen peroxide gas plasma sterilization for endoscopes using various Sterrad models. J. Hosp. Infect. 2005;59:280-5.
  894. Timm D, Gonzales D. Effect of sterilization on microstructure and function of microsurgical scissors. Surg. Serv. Management 1997;3:47-9.
  895. Feldman LA, Hui HK. Compatibility of medical devices and materials with low-temperature hydrogen peroxide gas plasma. Med. Dev. Diag. Indust. 1997;19:57-62.
  896. Muscarella LF. Leading a horse to water: Are crucial lessons in endoscopy and outbreak investigations being learned? Infect . Control Hosp. Epidemiol. 2002;23:358-60.
  897. Gurevich I, Qadri SMH, Cunha BA. False-positive results of spore tests from improper clip use with the Steris chemical sterilant system. Infect. Control Hosp. Epidemiol. 1992;21:42-3.
  898. Kralovic RC. Use of biological indicators designed for steam or ethylene oxide to monitor a liquid chemical sterilization process. Infect. Control Hosp. Epidemiol. 1993;14:313-9.
  899. Bond WW. Biological indicators for a liquid chemical sterilizer. Infect. Control Hosp. Epidemiol. 1993;14:565.
  900. Bond WW. Biological indicators for a liquid chemical sterilizer: a solution to the instrument reprocessing problem? Infect. Control Hosp. Epidemiol. 1993;14:309-12.
  901. Malchesky PS. Biological indicators for a liquid chemical sterilizer. Infect. Control Hosp. Epidemiol. 1993;14:563-6.
  902. Daschner F. STERIS SYSTEM 1 in Germany. Infect. Control Hosp. Epidemiol. 1994;15:294, 296.
  903. Sorin M, Segal-Maurer S, Urban C, Combest A, Rahal JJ. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the STERIS System 1 Processor. Infect. Control Hosp. Epidemiol. 2001;22:409-13.
  904. Food and Drug Administration, Division of General and Restorative Devices. Guidance on Premarket Notification [510(k)] Submissions for Sterilizers Intended for Use in Health Care Facilities. Rockville, MD. 1993.
  905. Vickery K, Deva AK, Zou J, Kumaradeva P, Bissett L, Cossart YE. Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: laboratory and 'in use' testing. J. Hosp. Infect. 1999;41:317-22.
  906. Vassal S, Favennec L, Ballet JJ, Brasseur P. Hydrogen peroxide gas plasma sterilization is effective against Cryptosporidium parvum oocysts. Am. J. Infect. Control 1998;26:136-8.
  907. Penna TC, Ferraz CA, Cassola MA. The presterilization microbial load on used medical devices and the effectiveness of hydrogen peroxide gas plasma against Bacillus subtilis spores. Infect. Control Hosp. Epidemiol. 1999;20:465-72.
  908. Bryce EA, Chia E, Logelin G, Smith JA. An evaluation of the AbTox Plazlyte Sterilization System. Infect. Control Hosp. Epidemiol. 1997;18:646-53.
  909. Graham GS, Riley R. Sterilization manufacturers: Interactions with regulatory agencies. In: Rutala WA, ed. Disinfection, sterilization, and antisepsis in healthcare. Champlain, New York: Polyscience Publications, 1998:41-8.
  910. Royce A, Bowler C. Ethylene oxide sterilisation-some experiences and some practical limitations. J. Pharm. Pharmacol. 1961;13:87t-94t.
  911. Nystrom B. Disinfection of surgical instruments. J. Hosp. Infect. 1981;2:363-8.
  912. Rutala WA, Gergen MF, Jones JF, Weber DJ. Levels of microbial contamination on surgical instruments. Am. J. Infect. Control 1998;26:143-5.
  913. Alfa MJ, Nemes R. Inadequacy of manual cleaning for reprocessing single-use, triple-lumen sphinctertomes: Simulated-use testing comparing manual with automated cleaning methods. Am. J. Infect. Control 2003;31:193-207.
  914. Alfa MJ, Nemes R. Reprocessing of lumened instruments. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington DC: Association for Professionals in Infection Control and Epidemiology, 2004:189-99.
  915. Bargmann LS, Bargmann BC, Collier JP, Currier BH, Mayor MB. Current sterilization and packaging methods for polyethylene. Clin. Orthop. 1999:49-58.
  916. Williams IR, Mayor MB, Collier JP. The impact of sterilization method on wear in knee arthroplasty. Clin. Orthop. 1998:170-80.
  917. Russell AD. Ionizing radiation. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and practices of disinfection, preservation and sterilization. Oxford: Blackwell Science, 1999:675-87.
  918. Hansen JM, Shaffer HL. Sterilization and preservation by radiation sterilization. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:729-46.
  919. Lagergren ER. Recent advances in sterilization. J Infect Control (Asia) 1998;1:11-3.
  920. Perkins JJ. Principles and methods of sterilization in health sciences. Springfield, IL: Charles C Thomas, 1969.
  921. Favero MS, Bond WW. The use of liquid chemical germicides. In: Morrissey RF, Phillips GB, eds. Sterilization technology: A practical guide for manufacturers and users of health care products. New York: Van Nostrand Reinhold, 1993:309-334.
  922. Muscarella LF. Are all sterilization processes alike? AORN J. 1998;67:966-70, 973-6.
  923. Levy RV. Sterile filtration of liquids and gases. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:795-822.
  924. Wallhausser KH. Is the removal of microorganisms by filtration really a sterilization method? J. Parenter. Drug Assoc. 1979;33:156-70.
  925. Webb BC, Thomas CJ, Harty DW, Willcox MD. Effectiveness of two methods of denture sterilization. J. Oral Rehabil. 1998;25:416-23.
  926. Rohrer MD, Bulard RA. Microwave sterilization. J. Am. Dent. Assoc. 1985;110:194-8.
  927. Rohrer MD, Terry MA, Bulard RA, Graves DC, Taylor EM. Microwave sterilization of hydrophilic contact lenses. Am. J. Ophthalmol. 1986;101:49-57.
  928. Douglas C, Burke B, Kessler DL, Cicmanec JF, Bracken RB. Microwave: practical cost-effective method for sterilizing urinary catheters in the home. Urology 1990;35:219-22.
  929. Kindle G, Busse A, Kampa D, Meyer-Konig U, Daschner FD. Killing activity of microwaves in milk. J. Hosp. Infect. 1996;33:273-8.
  930. Harris MG, Rechberger J, Grant T, Holden BA. In-office microwave disinfection of soft contact lenses. Optom. Vis. Sci. 1990;67:129-32.
  931. Mervine J, Temple R. Using a microwave oven to disinfect intermittent-use catheters. Rehabil. Nurs. 1997;22:318-20.
  932. Najdovski L, Dragas AZ, Kotnik V. The killing activity of microwaves on some non-sporogenic and sporogenic medically important bacterial strains. J. Hosp. Infect. 1991;19:239-47.
  933. Rosaspina S, Salvatorelli G, Anzanel D, Bovolenta R. Effect of microwave radiation on Candida albicans. Microbios 1994;78:55-9.
  934. Welt BA, Tong CH, Rossen JL, Lund DB. Effect of microwave radiation on inactivation of Clostridium sporogenes (PA 3679) spores. Appl. Environ. Microbiol. 1994;60:482-8.
  935. Latimer JM, Matsen JM. Microwave oven irradiation as a method for bacterial decontamination in a clinical microbiology laboratory. J. Clin. Microbiol. 1977;6:340-2.
  936. Sanborn MR, Wan SK, Bulard R. Microwave sterilization of plastic tissue culture vessels for reuse. Appl. Environ. Microbiol. 1982;44:960-4.
  937. Rosaspina S, Salvatorelli G, Anzanel D. The bactericidal effect of microwaves on Mycobacterium bovis dried on scalpel blades. J. Hosp. Infect. 1994;26:45-50.
  938. Engelhardt JP, Grun L, Dahl HJ. Factors affecting sterilization in glass bead sterilizers. J. Endod. 1984;10:465-70.
  939. Smith GE. Glass bead sterilization of orthodontic bands. Am. J. Orthod. Dentofacial Orthop. 1986;90:243-9.
  940. Sisco V, Winters LL, Zange LL, Brennan PC. Efficacy of various methods of sterilization of acupuncture needles. J. Manip. Physiol. Therap. 1988;11:94-7.
  941. Klapes NA, Vesley D. Vapor-phase hydrogen peroxide as a surface decontaminant and sterilant. Appl. Environ. Microbiol. 1990;56:503-6.
  942. French GL, Otter JA, Shannon KP, Adams NMT, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): A comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J. Hosp. Infect. 2004;57:31-7.
  943. Jeanes A, Rao G, Osman M, Merrick P. Eradication of persistent environmental MRSA. J. Hosp. Infect. 2005;61:85-6.
  944. Bates CJ, Pearse R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J. Hosp. Infect. 2005;61:364-6.
  945. Boyce JM, Havill NL, Otter JA, et al. Impact of hydrogen peroxide vapor room bio-decontamination on environmental contamination and nosocomial transmission of Clostridium difficile. The Society of Healthcare Epidemiology of America, 2006;Abstract 155:109.
  946. Berrington AW, Pedler SJ. Investigation of gaseous ozone for MRSA decontamination of hospital side-rooms. J. Hosp. Infect. 1998;40:61-5.
  947. Gaspar MC, Pelaez B, Fernandez C, Fereres J. Microbiological efficacy of Sterrad 100S and LTSF sterilisation systems compared to ethylene oxide. Zentr. Steril. 2002;10:91-9.
  948. Kanemitsu K, Kunishima H, Imasaka T, et al. Evaluation of a low-temperature steam and formaldehyde sterilizer. J. Hosp. Infect. 2003;55:47-52.
  949. Kanemitsu K, Imasaka T, Ishikawa S, et al. A comparative study of ethylene oxide gas, hydrogen peroxide gas plasma, and low-temperature steam formaldehyde sterilization. Infect Control Hosp Epidemiol 2005;26:486-9.
  950. Roncoroni AJ, Casewell MW, Phillips I. The disinfection of clinically contaminated Matburn suction pumps and baby incubators in an 'Aseptor' formalin cabinet. J. Hosp. Infect. 1980;1:251-9.
  951. Cumberland NS, Botting FG. Formaldehyde vapour cabinets. J. Hosp. Infect. 1991;19:67-70.
  952. Jeng DK, Woodworth AG. Chlorine dioxide gas sterilization of oxygenators in an industrial scale sterilizer: a successful model. Artif. Organs 1990;14:361-8.
  953. Knapp JE, Battisti DL. Chloride dioxide. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:215-27.
  954. Kowalski JB. Sterilization of medical devices, pharmaceutical components, and barrier isolation systems with gaseous chlorine dioxide. In: Morrissey RF, Kowalski JB, eds. Sterilization of medical products,. Champlain, NY: Polyscience Publications, 1998:313-23.
  955. Portner DM, Hoffman RK. Sporicidal effect of peracetic acid vapor. Appl. Microbiol. 1968;16:1782-5.
  956. Mata-Portuguez VH, Perez LS, Acosta-Gio E. Sterilization of heat-resistant instruments with infrared radiation. Infect . Control Hosp. Epidemiol. 2002;23.
  957. Frey R. The structural and functional prerequisites for a central sterile supply department (CSSD). Zentr. Steril. 2000;8:128-40.
  958. Reich RR, Fleming W, Burgess DJ. Sterilization validation: it's not just for industry. Infect. Control Steril. Technol. 1996;2.
  959. American Institute of Architects. Guidelines for design and construction of hospital and health care facilities. Washington, DC: The American Institute of Architects Press, 2001.
  960. DesCoteaux JG, Poulin EC, Julien M, Guidoin R. Residual organic debris on processed surgical instruments. AORN J. 1995;62:23-30.
  961. Rutala WA, Weber DJ. A review of the use of gowns and drapes (single use and reusable) in healthcare. Infect. Control Hosp. Epidemiol. 2001;22:248-57.
  962. Association of peri-Operative Registered Nurses. Recommended practices for sterilization in the perioperative practice setting. AORN J. 2006;83:700-22.
  963. Taurasi R. Comfortable PPE? Maximum tray weight? Healthcare Purchasing News 2004;July:48.
  964. Chobin N, Furr D, Nuyttens A. Wet packs and plastic accessory cases. Infect Control Today 2004;August:24, 28-30.
  965. Dunkelberg H, Fleitmann-Glende F. Measurement of the microbial barrier effectiveness of sterilization containers in terms of the log reduction value for prevention of nosocomial infections. Am. J. Infect. Control 2006;34:285-9.
  966. Rutala WA, Weber DJ. Choosing a sterilization wrap. Infect. Control Today 2000;4:64,70.
  967. Maloney JM, Kohut RD. Infection control, barrier protection and the treatment environment. Dent. Hyg. (Chic). 1987;61:310-3.
  968. Mayworm D. Sterile shelf life and expiration dating. J. Hosp. Supply, Process. Distri. 1984;2:32-5.
  969. Cardo DM, Sehulster LM. Central sterile supply. In: Mayhall CG, ed. Infect. Control and Hosp. Epidemiol. Philadelphia: Lippincott Williams & Wilkins, 1999:1023-30.
  970. Klapes NA, Greene VW, Langholz AC. Microbial contamination associated with routine aseptic practice. J. Hosp. Infect. 1987;10:299-304.
  971. Butt WE, Bradley DV, Jr., Mayhew RB, Schwartz RS. Evaluation of the shelf life of sterile instrument packs. Oral Surg. Oral Med. Oral Pathol. 1991;72:650-4.
  972. Webster J, Lloyd W, Ho P, Burridge C, George N. Rethinking sterilization practices: Evidence for event-related outdating. Infect Control Hosp Epidemiol 2003;24:622-4.
  973. Widmer AF, Houston A, Bollinger E, Wenzel RP. A new standard for sterility testing for autoclaved surgical trays. J. Hosp. Infect. 1992;21:253-60.
  974. Schneider PM, Reich RR, Kirckof SS, Foltz WG. Perfomance of various steam sterilization indicators under optimum and sub-optimum exposure conditions. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington DC: Association for Professionals in Infection Control and Epidemiology, 2004:200-23.
  975. Greene VW. Control of sterilization process. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and practice of disinfection, preservation and sterilization. Oxford, England: Blackwell Scientific Publications, 1992:605-24.
  976. Vesley D, Nellis MA, Allwood PB. Evaluation of a rapid readout biological indicator for 121oC gravity and 132oC vacuum-assisted steam sterilization cycles. Infect. Control Hosp. Epidemiol. 1995;16:281-6.
  977. Rutala WA, Jones SM, Weber DJ. Comparison of a rapid readout biological indicator for steam sterilization with four conventional biological indicators and five chemical indicators. Infect. Control Hosp. Epidemiol. 1996;17:423-8.
  978. Alfa MJ, Olson N, DeGagne P, Jackson M. Evaluation of rapid readout biological indicators for 132oC gravity and 132oC vacuum-assisted steam sterilization cycles using a new automated fluorescent reader. Infect . Control Hosp. Epidemiol. 2002;23:388-92.
  979. Koncur P, Janes JE, Ortiz PA. 20 second sterilization indicator tests equivalent to BIs. Infect. Control Steril. Technol. 1998:26-8, 30, 32-4.
  980. Perkins RE, Bodman HA, Kundsin RB, Walter CW. Monitoring steam sterilization of surgical instruments: a dilemma. Appl. Environ. Microbiol. 1981;42:383-7.
  981. Kotilainen HR, Gantz NM. An evaluation of three biological indicator systems in flash sterilization. Infect. Control 1987;8:311-6.
  982. Kleinegger CL, Yeager DL, Huling JK, Drake DR. The effects of contamination on biological monitoring. Infect. Control Hosp. Epidemiol. 2001;22:391-2.
  983. Centers for Disease Control. False-positive results of spore tests in ethylene oxide sterilizers - Wisconsin. MMWR 1981;30:238-40.
  984. Association of Operating Room Nurses. AORN standards and recommended practices for perioperative nursing. 1987:Section III:14.1-III:14.11, AORN, Denver, CO.
  985. Gurevich I, Holmes JE, Cunha BA. Presumed autoclave failure due to false-positive spore strip tests. Infect. Control 1982;3:388-92.
  986. Epstein BJ, Lattimer JM, Matsen JM, Garibaldi RA. False positive spore strip sterility tests with steam sterilization. Am. J. Infect. Control 1983;11:71-3.
  987. Association for the Advancement of Medical Instrumentation. Good hospital practice: steam sterilization and sterility assurance. Arlington, VA: AAMI, 1988.
  988. Baird RM. Sterility assurance: Concepts, methods and problems. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and practice of disinfection, preservation and sterilization. Oxford, England: Blackwell Scientific Publications, 1999:787-99.
  989. Coulter WA, Chew-Graham CA, Cheung SW, Burke FJT. Autoclave performance and operator knowledge of autoclave use in primary care: a survey of UK practices. J. Hosp. Infect. 2001;48:180-5.
  990. Greene VW. Reuse of disposable devices. In: Mayhall CG, ed. Infect. Control and Hosp. Epidemiol. Philadelphia: Lippincott Williams & Wilkins, 1999:1201-8.
  991. Avitall B, Khan M, Krum D, Jazayeri M, Hare J. Repeated use of ablation catheters: a prospective study. J. Am. Coll. Cardiol. 1993;22:1367-72.
  992. Dunnigan A, Roberts C, McNamara M, Benson DW, Jr., Benditt DG. Success of re-use of cardiac electrode catheters. Am. J. Cardiol. 1987;60:807-10.
  993. Aton EA, Murray P, Fraser V, Conaway L, Cain ME. Safety of reusing cardiac electrophysiology catheters. Am. J. Cardiol. 1994;74:1173-5.
  994. Brown SA, Merritt K, Woods TO, McNamee SG, Hitchins VM. Effects of different disinfection and sterilization methods on tensile strength of materials used for single-use devices. Biomed. Instrum. Technol 2002;January/February:23-7.
  995. Food and Drug Administration. Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals, Rockville, MD., 2000.
  996. Ulatowski TA. FDA: Reuse of Single-Use Devices. In: Rutala WA, ed. Disinfection, sterilization and antisepsis: Principles, practices, challenges, and new research. Washington, DC: Association for Professionals in Infection Control and Epidemiology, 2004:15-23.
  997. Occupational Health and Safety Administration. Hazard Communication Standard.29 CFR 1910.1200, OSHA, Washington, DC.
  998. Edens AL. Occupational Safety and Health Administration: Regulations affecting healthcare facilities. In: Rutala WA, ed. Disinfection, Sterilization and Antisepsis: Principles and practices in healthcare facilities. Washington, D.C,: Association for Professionals in Infection Control and Epidemiology, Inc., 2001:49-58.
  999. Schultz JK. Decontamination: recommended practices. In: Reichert M, Young JH, eds. Sterilization technology for the health care facility. Gaithersburg, MD: Aspen Publication, 1997:10-20.
  1000. Occupational Health and Safety Administration. Ethylene Oxide Standard. Vol. 29 CFR 1910.1047, OSHA, Washington, DC.
  1001. Occupational Safety and Health Administration. Formaldehyde Standard. Vol. 29 CFR 1910.1048, Washington, DC.
  1002. Buxton AE, Anderson RL, Werdegar D, Atlas E. Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics. Am. J. Med. 1978;65:507-13.
  1003. Snydman DR. Hepatitis B infection from medical personnel. JAMA 1976;236:1009.
  1004. Martiny H, Floss H. Residuals on medical devices following reprocessing. J. Hosp. Infect. 2001;48 (Supplement):S88-S92.
  1005. Taylor DM. Inactivation of prions by physical and chemical means. J. Hosp. Infect. 1999;43 (supplement):S69-S76.
  1006. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Comparative mycobactericidal efficacy of chemical disinfectants in suspension and carrier tests. Appl. Environ. Microbiol. 1988;54:2856-8.
  1007. Weber DJ, Rutala WA. Environmental issues and nosocomial infections. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams and Wilkins, 1991:1042-64.
  1008. Palmer PH, Yeoman DM. A study to assess the value of disinfectants when washing ward floors. Med. J. Aust. 1972;2:1237-9.
  1009. Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance - report from the Hospital Infection Control Practices Advisory Committee. Fed. Regist. 1994:25758-63.
  1010. Ayliffe GA, Collins BJ, Lowbury EJ. Cleaning and disinfection of hospital floors. BMJ 1966;5511:442-5.
  1011. Neely AN. A survey of gram-negative bacteria survival on hospital fabrics and plastics. J. Burn Care Rehabil. 2000;21:523-7.
  1012. Rutala WA. Disinfection and sterilization of patient-care items. Infect. Control Hosp. Epidemiol. 1996;17:377-84.
  1013. Environmental Protection Agency. Pesticides: Regulating Pesticides. http ;//www.epa.gov/oppad001/chemregindex.htm, 2003.
  1014. Hoffman PN, Layzell SK. Household bleach as disinfectant for use by injecting drug users. Lancet 1993;342:743.
  1015. Chu NS, Chan-Myers H, Ghazanfari N, Antonoplos P. Levels of naturally occurring microorganisms on surgical instruments after clinical use and after washing. Am. J. Infect. Control 1999;27:315-9.
  1016. Hoffmann KK, Weber DJ, Rutala WA. Pseudoepidemic of Rhodotorula rubra in patients undergoing fiberoptic bronchoscopy. Infect. Control Hosp. Epidemiol. 1989;10:511-4.
  1017. Lowry PW, Jarvis WR. Use of tap water and disinfection practices in outpatient settings. A survey of otolaryngologists. Arch. Otolaryngol. Head Neck Surg. 1991;117:886-8.
  1018. Fahey BJ, Koziol DE, Banks SM, Henderson DK. Frequency of nonparenteral occupational exposures to blood and body fluids before and after universal precautions training. Am. J. Med. 1991;90:145-53.
  1019. Beekmann SE, Vlahov D, Koziol DE, McShalley ED, Schmitt JM, Henderson DK. Temporal association between implementation of universal precautions and a sustained, progressive decrease in percutaneous exposures to blood. Clin. Infect. Dis. 1994;18:562-9.
  1020. Gerberding JL, Littell C, Tarkington A, Brown A, Schecter WP. Risk of exposure of surgical personnel to patients' blood during surgery at San Francisco General Hospital. N. Engl. J. Med. 1991;324:1788-93.
  1021. Mast ST, Woolwine JD, Gerdberding JL. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury. J. Infect. Dis. 1993;168:1589-92.
  1022. Wendt C, Herwaldt LA. Epidemics: Identification and Management. In: Wenzel RP, ed. Prevention and Control of Nosocomial Infections. Baltimore: Williams & Wilkins, 1997:175-214.
  1023. Feigal DW, Gardner SN, McClellan M. Ensuring safe and effective medical devices. N. Engl. J. Med. 2003;348:191-2.
  1024. Oie S, Kamiya A. Microbial contamination of antiseptics and disinfectants. Am. J. Infect. Control 1996;24:389-95.
  1025. Strzelecki LR, Nelson JH. Evaluation of closed container flash sterilization system. Orthop. Nurs. 1989;8:21-4.
  1026. Burgess DJ, Reich RR. Industrial ethylene oxide sterilization. In: Morrissey RF, Phillips GB, eds. Sterilization technology: a practical guide for manufacturers and users of health care product. New York: Van Nostrand Reinhold, 1993:120-51.
  1027. Conviser CA, C W. Ethylene oxide sterilization: sterilant alternatives. In: Reichert M, Young JH, eds. Sterilization technology for the health care facility. Gaithersburg, MD: Aspen Publication, 1997:189-99.
  1028. Young JH. Steam sterilization: scientific principles. In: Reichert M, Young JH, eds. Sterilization technology for the health care facility. Gaithersburg, MD: Aspen Publication, 1997:123-144.
  1029. Alfa MJ. Importance of lumen flow in liquid chemical sterilization. Am. J. Infect. Control 1999;27:373-5.
  1030. Mallison GF, Standard PG. Safe storage times for sterile packs. Hospitals 1974;48:77-8, 80.
  1031. Klapes NA, Greene VW, Langholz AC, Hunstiger C. Effect of long-term storage on sterile status of devices in surgical packs. Infect. Control 1987;8:289-93.
  1032. Japp NF. Packaging: Shelf life. In: Reichert M, Young JH, eds. Sterilization Technology. Gaithersburg, Maryland: Aspen, 1997:99-102.
  1033. Joint Commission for the Accreditation of Healthcare Organizations. Comprehensive accreditation manual for hospitals, JCAHO, Chicago, IL. 2003.
  1034. Block SS. Definition of terms. In: Block SS, ed. Disinfection, sterilization, and preservation. Philadelphia: Lippincott Williams & Wilkins, 2001:19-28.
  1035. Molinari JA, Gleason MJ, Cottone JA, Barrett ED. Comparison of dental surface disinfectants. Gen. Dent. 1987;35:171-5.
 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC–INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #